Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.

paper Cited Public

Authors: Demontis, Ditte; Walters, Raymond K; Martin, Joanna; Mattheisen, Manuel; Als, Thomas D; Agerbo, Esben; Baldursson, Gísli; Belliveau, Rich; Bybjerg-Grauholm, Jonas; Bækvad-Hansen, Marie; Cerrato, Felecia; Chambert, Kimberly; Churchhouse, Claire; Dumont, Ashley; Eriksson, Nicholas; Gandal, Michael; Goldstein, Jacqueline I; Grasby, Katrina L; Grove, Jakob; Gudmundsson, Olafur O; Hansen, Christine S; Hauberg, Mads Engel; Hollegaard, Mads V; Howrigan, Daniel P; Huang, Hailiang; Maller, Julian B; Martin, Alicia R; Martin, Nicholas G; Moran, Jennifer; Pallesen, Jonatan; Palmer, Duncan S; Pedersen, Carsten Bøcker; Pedersen, Marianne Giørtz; Poterba, Timothy; Poulsen, Jesper Buchhave; Ripke, Stephan; Robinson, Elise B; Satterstrom, F Kyle; Stefansson, Hreinn; Stevens, Christine; Turley, Patrick; Walters, G Bragi; Won, Hyejung; Wright, Margaret J; ADHD Working Group of the Psychiatric Genomics Consortium (PGC); Early Lifecourse & Genetic Epidemiology (EAGLE) Consortium; 23andMe Research Team; Andreassen, Ole A; Asherson, Philip; Burton, Christie L; Boomsma, Dorret I; Cormand, Bru; Dalsgaard, Søren; Franke, Barbara; Gelernter, Joel; Geschwind, Daniel; Hakonarson, Hakon; Haavik, Jan; Kranzler, Henry R; Kuntsi, Jonna; Langley, Kate; Lesch, Klaus-Peter; Middeldorp, Christel; Reif, Andreas; Rohde, Luis Augusto; Roussos, Panos; Schachar, Russell; Sklar, Pamela; Sonuga-Barke, Edmund J S; Sullivan, Patrick F; Thapar, Anita; Tung, Joyce Y; Waldman, Irwin D; Medland, Sarah E; Stefansson, Kari; Nordentoft, Merete; Hougaard, David M; Werge, Thomas; Mors, Ole; Mortensen, Preben Bo; Daly, Mark J; Faraone, Stephen V; Børglum, Anders D; Neale, Benjamin M
Year: 2019
Journal: Nature genetics
PMID: 30478444
DOI: 10.1038/s41588-018-0269-7
PMCID: PMC6481311

Figure 1.

Manhattan plot of the results from the GWAS meta-analysis of ADHD.The index variants in the 12 genome-wide significant loci are highlighted as a green diamond. Index variants located with a distance less than 400kb are considered as one locus. The y-axis represents –log(two-sided P-values) for association of variants with ADHD, from meta-analysis using an inverse-variance weighted fixed effects model, and a total sample size of 20,183 ADHD cases and 35,191 controls. The vertical red line represents the threshold for genome-wide significance.

Figure 2.

Odds Ratio by PRS for ADHDOdds Ratio (OR) by PRS within each decile estimated for n = 18,298 biological independent individuals in the PGC samples (red dots) and in n = 37,076 biological independent individuals in the iPSYCH sample (blue dots). PRSs in the iPSYCH sample were obtained by five leave-one-out analyses, using 4 of 5 groups as training datasets for estimation of SNP weights, while estimating Polygenic Risk Scores (PRS) for the remaining target group. Odds ratios and 95% confidence limits (error bars) were estimated using logistic regression on the continuous scores.

Figure 3.

Genetic correlations of ADHD with other phenotypesSignificant genetic correlations between ADHD (results from Europena GWAS meta-analysis of 19,099 cases, 34,194 controls) and other traits reveal overlap of genetic risk factors for ADHD across several groups of traits (grouping indicated by a horizontal line): educational, psychiatric/personality, weight (and possible weight related traits), smoking behaviour/smoking-related cancer, reproductive traits and parental longevity (Sample size of the external GWASs are presented in Supplementary Table 5). In total 219 traits were tested and only traits significant after Bonferroni correction are presented in the figure. Two significant educational phenotypes are omitted due to substantial overlap with years of schooling. Genetic correlation is presented as a dot and error bars indicate 95% confidence limits.

#	Section	Preview
0	Introduction	Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental psychiatric disorder, that…
1	Introduction	Consensus estimates from over 30 twin studies indicate that the heritability of ADHD is 70–80%…
2	Introduction	Thus far genome-wide association studies (GWASs) to identify common DNA variants that increase the…
3	Introduction	Previous studies have demonstrated that the common variant risk, also referred to as the single…
4	Introduction	Here we present a genome-wide meta-analysis identifying the first genome-wide significant loci for…
5	Results — Genome-wide significantly associated ADHD risk loci	Genotype array data for 20,183 ADHD cases and 35,191 controls were collected from 12 cohorts…
6	Results — Genome-wide significantly associated ADHD risk loci	Prior to analysis, stringent quality control procedures were performed on the genotyped markers and…
7	Results — Genome-wide significantly associated ADHD risk loci	GWAS was conducted in each cohort using logistic regression with the imputed additive genotype…
8	Results — Genome-wide significantly associated ADHD risk loci	In total, 304 genetic variants in 12 loci surpassed the threshold for genome-wide significance…
9	Results — Homogeneity of effects between cohorts	No genome-wide significant heterogeneity was observed in the ADHD GWAS meta-analysis (Supplementary…
10	Results — Homogeneity of effects between cohorts	Polygenic risk scores (PRS)38 were also consistent across target samples. PRS computed in each PGC…
11	Results — Polygenic Architecture of ADHD	To assess the proportion of phenotypic variance explained by common variants we applied LD score…
12	Results — Polygenic Architecture of ADHD	To further characterize the patterns of heritability from the genome-wide association data, we…
13	Results — Genetic correlation with other traits	Pairwise genetic correlation with ADHD was estimated for 219 phenotypes using LD score…
14	Results — Genetic correlation with other traits	number of cigarettes smoked (rg = 0.45, P = 1.07 × 10−5) are reinforced by significant positive…
15	Results — Biological annotation of significant loci	For the 12 genome-wide significant loci, Bayesian credible sets were defined to identify the set of…
16	Results — Biological annotation of significant loci	Here we highlight genes that are identified in the regions of association (see also Supplementary…
17	Results — Biological annotation of significant loci	Genome-wide significant loci on chromosomes 12 and 15 have more biological annotations supporting…
18	Results — Biological annotation of significant loci	Credible set annotations at the remaining loci are more diverse (Supplementary Data 3). The most…
19	Results — Biological annotation of significant loci	On chromosome 5, the credible set includes links to LINC00461 and TMEM161B (Supplementary Data 3).…

Name	Type
1000 Genomes phase 3 European ancestry samples local	cohort
1000 Genomes Project	cohort
1000 Genomes Project phase 3 (1KGP3) local	cohort
12 study cohorts local	cohort
23andMe	cohort
23andMe dataset local	cohort
ADHD	phenotype
ADHD GWAS	cohort
ADHD GWAS meta-analysis local	cohort
ADHD-related behaviors local	phenotype
ADHD-related traits local	phenotype
ADHD risk variants local	variant
ADHD status local	phenotype
ADHD symptoms	phenotype
age at first birth	phenotype
AIDS risk behaviors local	phenotype
Alzheimer’s disease	phenotype
anorexia nervosa	phenotype
Antisocial personality disorder/behaviours local	phenotype
autism spectrum disorder	phenotype
autosomal recessive intellectual disability local	phenotype
basal ganglia	anatomy
BIOS	cohort
BIOS79 local	cohort
bipolar disorder	phenotype
body mass index	phenotype
brain	anatomy
CADPS2 local	gene
central nervous system	anatomy
cerebral malformation local	phenotype
childhood obesity	phenotype
Chinese	cohort
Chinese ancestry cohort local	cohort
cigarettes	phenotype
cognition	phenotype
college completion	phenotype
college/university degree local	phenotype
common variant risk for ADHD local	variant
common variants	cohort
conduct disorder	phenotype
constrained genes local	gene
continuous measures of ADHD symptoms local	phenotype
continuous phenotype	phenotype
cortical and subcortical plate local	anatomy
crime	phenotype
death	phenotype
deCODE	cohort
deCODE Icelandic cohort local	cohort
Denmark cohort	cohort
depression	phenotype
depressive symptoms	phenotype
developing human cerebral cortex local	anatomy
developmental disorders of language and learning local	phenotype
dichotomous phenotype local	phenotype
dopamine	drug
DUSP6 local	gene
EAGLE30/QIMR92 local	cohort
EAGLE consortium	cohort
EAGLE/QIMR local	cohort
EAGLE sample local	cohort
educational attainment	phenotype
educational outcomes	phenotype
Education-related phenotypes local	phenotype
European ancestry	cohort
European ancestry PGC case/control local	cohort
European ancestry PGC samples local	cohort
European GWAS meta-analysis local	cohort
European population	cohort
Europeans	cohort
ever smoking	phenotype
ExAC	cohort
families	cohort
fetal brain	anatomy
Foxp2	gene
FOXP2 downstream target genes local	gene
GCTA	drug
germinal zone local	anatomy
GTEx	cohort
GTEx127 local	cohort
H3K4me1	drug
HapMap3	cohort
HDL cholesterol	phenotype
Health care utilization local	phenotype
heavy drinking	phenotype
higher fecundity local	phenotype
highly constrained genes local	gene
human intelligence local	phenotype
Hyperactive/impulsive trait local	phenotype
ICD10 F90.0 local	phenotype
Illumina PsychChip local	drug
Inattentive trait local	phenotype
inferior frontal gyrus	anatomy
insomnia	phenotype
iPSYCH	cohort
iPSYCH cohort	cohort
iPSYCH sample	cohort
LD Hub	cohort
lead chromosome 1 locus local	variant
lead index variant local	variant
LINC00461 local	gene
LINC01572 local	gene
LOC105379109 local	gene
lung cancer	phenotype
MAGMA	drug
major depressive disorder	phenotype
MEF2C	gene
MEF2C-AS1 local	gene
memory	phenotype
Motor vehicle accidents	phenotype
mouse brain	anatomy
neurodevelopmental traits local	phenotype
neuroticism	phenotype
number of children ever born	phenotype
number of cigarettes smoked per day	phenotype
obesity	phenotype
obesity-related phenotype	phenotype
parental divorce/separation	phenotype
PGC	cohort
PGC cohorts	cohort
polygenic risk score	cohort
poor language skills local	phenotype
Primary ADHD GWAS local	cohort
protein-truncating variants local	variant
Psychiatric Central Research Register local	cohort
psychiatric disorders	phenotype
Psychiatric Genomics Consortium	cohort
PTPRF	gene
QIMR	cohort
QIMR cohort	cohort
quantitative ADHD symptom scores local	phenotype
rare and de novo variants local	variant
reaction time	phenotype
reduced educational attainment local	phenotype
reproduction local	phenotype
Ricopili	drug
risky sexual behaviour local	phenotype
RNF219-AS1 local	gene
Roadmap128 local	cohort
Roadmap Epigenomics Mapping Consortium local	cohort
rs11210892 local	variant
rs112984125 local	variant
rs11420276 local	variant
rs11591402 local	variant
rs12410155 local	variant
rs1427829 local	variant
rs1443749 local	variant
rs1592757 local	variant
rs212178 local	variant
rs2243638 local	variant
rs28452470 local	variant
rs30266 local	variant
rs304132 local	variant
rs5886709 local	variant
rs9574218 local	variant
rs9677504 local	variant
schizophrenia	phenotype
secondary signal	variant
SEMA6D local	gene
severe intellectual disability local	phenotype
SLC9A9	gene
Sleep-related phenotypes local	phenotype
smoking	phenotype
SNP	cohort
SNP heritability	phenotype
SORCS3	gene
SPAG16 local	gene
ST3GAL3	gene
study cohort	cohort
subjective well-being	phenotype
substance abuse	phenotype
suicide	phenotype
target groups local	cohort
TMEM161B	gene
trauma	phenotype
trio cohorts local	cohort
trios	cohort
Twin cohort	cohort
type 2 diabetes	phenotype
UK_Biobank local	cohort
unemployment	phenotype
verbal–numerical reasoning local	phenotype
waist-to-hip ratio	phenotype
years of education	phenotype
younger parental age local	phenotype

Citation	PMID	DOI	Status
AnttilaV Analysis of shared heritability in common disorders of the brain. BioRxiv, 1–22 (2016).10.1126/science.aap8757PMC609723729930110	—	—	—
BarbanN Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Nature genetics 48, 1462–1472, doi:10.1038/ng.3698 (2016).27798627PMC5695684	—	—	—
BarbaresiWJ, KatusicSK, ColliganRC, WeaverAL & JacobsenSJ Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr 28, 265–273, doi:10.1097/DBP.0b013e31811ff87d (2007).17700078	—	—	—
BarkleyRA, MurphyKR & FischerM ADHD in adults What the Science Says. (The Guilford Press, 2007).	—	—	—
BenyaminB Childhood intelligence is heritable, highly polygenic and associated with FNBP1L. Molecular psychiatry 19, 253–258, doi:10.1038/mp.2012.184 (2014).23358156PMC3935975	—	—	—
BerndtSI Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nature genetics 45, 501–512, doi:10.1038/ng.2606 (2013).23563607PMC3973018	—	—	—
BiedermanJ & FaraoneSV Attention-deficit hyperactivity disorder. Lancet 366, 237–248, doi:10.1016/S0140-6736(05)66915-2 (2005).16023516	—	—	—
BradfieldJP A genome-wide association meta-analysis identifies new childhood obesity loci. Nature genetics 44, 526–531, doi:10.1038/ng.2247 (2012).22484627PMC3370100	—	—	—
BreiderhoffT Sortilin-related receptor SORCS3 is a postsynaptic modulator of synaptic depression and fear extinction. PloS one 8, e75006, doi:10.1371/journal.pone.0075006 (2013).24069373PMC3777878	—	—	—
Bulik-SullivanB An atlas of genetic correlations across human diseases and traits. Nature genetics 47, 1236–1241, doi:10.1038/ng.3406 (2015).26414676PMC4797329	—	—	—
Bulik-SullivanBK LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nature genetics 47, 291–295, doi:10.1038/ng.3211 (2015).25642630PMC4495769	—	—	—
BurtSA Rethinking environmental contributions to child and adolescent psychopathology: a meta-analysis of shared environmental influences. Psychological bulletin 135, 608–637, doi:10.1037/a0015702 (2009).19586164	—	—	—
CauntCJ & KeyseSM Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling. FEBS J 280, 489–504, doi:10.1111/j.1742-4658.2012.08716.x (2013).22812510PMC3594966	—	—	—
ChangCC Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7, doi:10.1186/s13742-015-0047-8 (2015).25722852PMC4342193	—	—	—
ChangZ Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study. Int J Epidemiol 43, 1815–1824, doi:10.1093/ije/dyu204 (2014).25355726PMC4276066	—	—	—
ChangZ, LichtensteinP, D'OnofrioBM, SjolanderA & LarssonH Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry 71, 319–325, doi:10.1001/jamapsychiatry.2013.4174 (2014).24477798PMC3949159	—	—	—
ChenAY, KimSE, HoutrowAJ & NewacheckPW Prevalence of obesity among children with chronic conditions. Obesity (Silver Spring) 18, 210–213, doi:10.1038/oby.2009.185 (2010).19521350	—	—	—
ChristiansenH Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder. J Neural Transm (Vienna) 115, 163–175, doi:10.1007/s00702-007-0837-y (2008).18200434	—	—	—
ChudalR Parental age and the risk of attention-deficit/hyperactivity disorder: a nationwide, population-based cohort study. Journal of the American Academy of Child and Adolescent Psychiatry 54, 487–494 e481, doi:10.1016/j.jaac.2015.03.013 (2015).26004664	—	—	—
ConsortiumGT Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660, doi:10.1126/science.1262110 (2015).25954001PMC4547484	—	—	—
ConsortiumGT The Genotype-Tissue Expression (GTEx) project. Nature genetics 45, 580–585, doi:10.1038/ng.2653 (2013).23715323PMC4010069	—	—	—
CorteseS Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis. The American journal of psychiatry 173, 34–43, doi:10.1176/appi.ajp.2015.15020266 (2016).26315982	—	—	—
CorteseS, ComenciniE, VincenziB, SperanzaM & AngrimanM Attention-deficit/hyperactivity disorder and impairment in executive functions: a barrier to weight loss in individuals with obesity? BMC psychiatry 13, 286, doi:10.1186/1471-244X-13-286 (2013).24200119PMC4226281	—	—	—
Cross-Disorder Group of the Psychiatric Genomics, C. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature genetics 45, 984–994, doi:10.1038/ng.2711 (2013).23933821PMC3800159	—	—	—
Cross-Disorder Group of the Psychiatric Genomics, C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379, doi:10.1016/S0140-6736(12)62129-1 (2013).23453885PMC3714010	—	—	—
DalsgaardS, LeckmanJF, MortensenPB, NielsenHS & SimonsenM Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. Lancet Psychiatry 2, 702–709, doi:10.1016/S2215-0366(15)00271-0 (2015).26249301	—	—	—
DalsgaardS, MortensenPB, FrydenbergM & ThomsenPH ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study. Addict Behav 39, 325–328, doi:10.1016/j.addbeh.2013.09.002 (2014).24090624	—	—	—
DalsgaardS, NielsenHS & SimonsenM Consequences of ADHD medication use for children's outcomes. J Health Econ 37, 137–151, doi:10.1016/j.jhealeco.2014.05.005 (2014).24997381	—	—	—
DalsgaardS, OstergaardSD, LeckmanJF, MortensenPB & PedersenMG Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet 385, 2190–2196, doi:10.1016/S0140-6736(14)61684-6 (2015).25726514	—	—	—
DaviesG Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151). Molecular psychiatry 21, 758–767, doi:10.1038/mp.2016.45 (2016).27046643PMC4879186	—	—	—
de LeeuwCA, MooijJM, HeskesT & PosthumaD MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol 11, e1004219, doi:10.1371/journal.pcbi.1004219 (2015).25885710PMC4401657	—	—	—
DelaneauO, MarchiniJ & ZaguryJF A linear complexity phasing method for thousands of genomes. Nature methods 9, 179–181, doi:10.1038/nmeth.1785 (2011).22138821	—	—	—
DuncanL Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa. The American journal of psychiatry 174, 850–858, doi:10.1176/appi.ajp.2017.16121402 (2017).28494655PMC5581217	—	—	—
EbejerJL Genome-wide association study of inattention and hyperactivity-impulsivity measured as quantitative traits. Twin Res Hum Genet 16, 560–574, doi:10.1017/thg.2013.12 (2013).23527680	—	—	—
ErnstJ & KellisM Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues. Nature biotechnology 33, 364–376 (2015).10.1038/nbt.3157PMC451230625690853	—	—	—
FaraoneSV & BiedermanJ Do attention deficit hyperactivity disorder and major depression share familial risk factors? The Journal of nervous and mental disease 185, 533–541 (1997).930761410.1097/00005053-199709000-00001	—	—	—
FaraoneSV Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers, 15020, doi:10.1038/nrdp.2015.20 (2015).27189265	—	—	—
FaraoneSV Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. Journal of abnormal psychology 102, 616–623 (1993).828293210.1037/0021-843X.102.4.616	—	—	—
FaraoneSV Molecular genetics of attention-deficit/hyperactivity disorder. Biological psychiatry 57, 1313–1323, doi:10.1016/j.biopsych.2004.11.024 (2005).15950004	—	—	—
FaraoneSV, BiedermanJ & WozniakJ Examining the comorbidity between attention deficit hyperactivity disorder and bipolar I disorder: a meta-analysis of family genetic studies. The American journal of psychiatry 169, 1256–1266, doi:10.1176/appi.ajp.2012.12010087 (2012).23212057	—	—	—
FinucaneHK Partitioning heritability by functional annotation using genome-wide association summary statistics. Nature genetics 47, 1228–1235, doi:10.1038/ng.3404 (2015).26414678PMC4626285	—	—	—
FloryK, MolinaBS, PelhamWEJr., GnagyE & SmithB Childhood ADHD predicts risky sexual behavior in young adulthood. J Clin Child Adolesc Psychol 35, 571–577, doi:10.1207/s15374424jccp3504_8 (2006).17007602	—	—	—
FrankeB The genetics of attention deficit/hyperactivity disorder in adults, a review. Molecular psychiatry 17, 960–987, doi:10.1038/mp.2011.138 (2012).22105624PMC3449233	—	—	—
FurczykK & ThomeJ Adult ADHD and suicide. Atten Defic Hyperact Disord 6, 153–158, doi:10.1007/s12402-014-0150-1 (2014).25063344	—	—	—
GalinskyKJ Fast Principal-Component Analysis Reveals Convergent Evolution of ADH1B in Europe and East Asia. American journal of human genetics 98, 456–472, doi:10.1016/j.ajhg.2015.12.022 (2016).26924531PMC4827102	—	—	—
Gene Ontology, C. Gene Ontology Consortium: going forward. Nucleic acids research 43, D1049–1056, doi:10.1093/nar/gku1179 (2015).25428369PMC4383973	—	—	—
Genomes ProjectC A global reference for human genetic variation. Nature 526, 68–74, doi:10.1038/nature15393 (2015).26432245PMC4750478	—	—	—
GhirardiL The familial co-aggregation of ASD and ADHD: a register-based cohort study. Molecular psychiatry, doi:10.1038/mp.2017.17 (2017).PMC579488128242872	—	—	—
Groen-BlokhuisMM Attention-deficit/hyperactivity disorder polygenic risk scores predict attention problems in a population-based sample of children. Journal of the American Academy of Child and Adolescent Psychiatry 53, 1123–1129 e1126, doi:10.1016/j.jaac.2014.06.014 (2014).25245356	—	—	—
GroveJ Common risk variants identified in autism spectrum disorder. bioRxiv, doi:10.1101/224774 (2017).	—	—	—
HalfonN, LarsonK & SlusserW Associations between obesity and comorbid mental health, developmental, and physical health conditions in a nationally representative sample of US children aged 10 to 17. Acad Pediatr 13, 6–13, doi:10.1016/j.acap.2012.10.007 (2013).23200634	—	—	—
HammerschlagAR Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits. Nature genetics 49, 1584–1592, doi:10.1038/ng.3888 (2017).28604731PMC5600256	—	—	—
HamshereML High loading of polygenic risk for ADHD in children with comorbid aggression. The American journal of psychiatry 170, 909–916, doi:10.1176/appi.ajp.2013.12081129 (2013).23599091PMC3935265	—	—	—
HamshereML Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. The British journal of psychiatry : the journal of mental science 203, 107–111, doi:10.1192/bjp.bp.112.117432 (2013).23703318PMC3730114	—	—	—
HarrowJ GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22, 1760–1774, doi:10.1101/gr.135350.111 (2012).22955987PMC3431492	—	—	—
HawiZ The molecular genetic architecture of attention deficit hyperactivity disorder. Molecular psychiatry 20, 289–297, doi:10.1038/mp.2014.183 (2015).25600112	—	—	—
HosainGM, BerensonAB, TennenH, BauerLO & WuZH Attention deficit hyperactivity symptoms and risky sexual behavior in young adult women. J Womens Health (Larchmt) 21, 463–468, doi:10.1089/jwh.2011.2825 (2012).22303821PMC3321673	—	—	—
HowieB, MarchiniJ & StephensM Genotype imputation with thousands of genomes. G3 1, 457–470, doi:10.1534/g3.111.001198 (2011).22384356PMC3276165	—	—	—
HuH ST3GAL3 mutations impair the development of higher cognitive functions. American journal of human genetics 89, 407–414, doi:10.1016/j.ajhg.2011.08.008 (2011).21907012PMC3169827	—	—	—
HydeCL Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nature genetics 48, 1031–1036, doi:10.1038/ng.3623 (2016).27479909PMC5706769	—	—	—
JensenCM & SteinhausenHC Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord 7, 27–38, doi:10.1007/s12402-014-0142-1 (2015).24942707	—	—	—
KongA Selection against variants in the genome associated with educational attainment. Proceedings of the National Academy of Sciences of the United States of America 114, E727–E732, doi:10.1073/pnas.1612113114 (2017).28096410PMC5293043	—	—	—
KundajeA Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).2569356310.1038/nature14248PMC4530010	—	—	—
KuntsiJ The separation of ADHD inattention and hyperactivity-impulsivity symptoms: pathways from genetic effects to cognitive impairments and symptoms. Journal of abnormal child psychology 42, 127–136, doi:10.1007/s10802-013-9771-7 (2014).23839718PMC4520068	—	—	—
LambertJC Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature genetics 45, 1452–1458, doi:10.1038/ng.2802 (2013).24162737PMC3896259	—	—	—
LarsonK, RussSA, KahnRS & HalfonN Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 127, 462–470, doi:10.1542/peds.2010-0165 (2011).21300675PMC3065146	—	—	—
LarssonH Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder. The British journal of psychiatry : the journal of mental science 203, 103–106, doi:10.1192/bjp.bp.112.120808 (2013).23703314PMC3730113	—	—	—
LarssonH, AnckarsaterH, RastamM, ChangZ & LichtensteinP Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs. J Child Psychol Psychiatry 53, 73–80, doi:10.1111/j.1469-7610.2011.02467.x (2012).21923806	—	—	—
Le MeurN MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet 47, 22–29, doi:10.1136/jmg.2009.069732 (2010).19592390PMC2848840	—	—	—
LeeSS, HumphreysKL, FloryK, LiuR & GlassK Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 31, 328–341, doi:10.1016/j.cpr.2011.01.006 (2011).21382538PMC3180912	—	—	—
LekM Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291, doi:10.1038/nature19057 (2016).27535533PMC5018207	—	—	—
LichtensteinP & LarssonH Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 368, 776, doi:10.1056/NEJMc1215531 (2013).23425178	—	—	—
Lindblad-TohK A high-resolution map of human evolutionary constraint using 29 mammals. Nature 478, 476–482, doi:10.1038/nature10530 (2011).21993624PMC3207357	—	—	—
LubkeGH, HudziakJJ, DerksEM, van BijsterveldtTC & BoomsmaDI Maternal ratings of attention problems in ADHD: evidence for the existence of a continuum. Journal of the American Academy of Child and Adolescent Psychiatry 48, 1085–1093, doi:10.1097/CHI.0b013e3181ba3dbb (2009).19797980PMC2782551	—	—	—
MarshLE, NorvilitisJM, IngersollTS & LiB ADHD symptomatology, fear of intimacy, and sexual anxiety and behavior among college students in China and the United States. J Atten Disord 19, 211–221, doi:10.1177/1087054712453483 (2015).22893505	—	—	—
MartinJ, HamshereML, StergiakouliE, O'DonovanMC & ThaparA Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population. Biological psychiatry 76, 664–671, doi:10.1016/j.biopsych.2014.02.013 (2014).24673882PMC4183378	—	—	—
McLarenW The Ensembl Variant Effect Predictor. Genome Biol 17, 122, doi:10.1186/s13059-016-0974-4 (2016).27268795PMC4893825	—	—	—
MiddeldorpCM A Genome-Wide Association Meta-Analysis of Attention-Deficit/Hyperactivity Disorder Symptoms in Population-Based Pediatric Cohorts. Journal of the American Academy of Child and Adolescent Psychiatry 55, 896–905 e896, doi:10.1016/j.jaac.2016.05.025 (2016).27663945PMC5068552	—	—	—
MorrisAP Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature genetics 44, 981–990, doi:10.1038/ng.2383 (2012).22885922PMC3442244	—	—	—
MortensenOV MKP3 eliminates depolarization-dependent neurotransmitter release through downregulation of L-type calcium channel Cav1.2 expression. Cell Calcium 53, 224–230, doi:10.1016/j.ceca.2012.12.004 (2013).23337371	—	—	—
MortensenOV, LarsenMB, PrasadBM & AmaraSG Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking. Mol Biol Cell 19, 2818–2829, doi:10.1091/mbc.E07-09-0980 (2008).18434601PMC2441689	—	—	—
NealeBM Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 49, 884–897, doi:10.1016/j.jaac.2010.06.008 (2010).20732625PMC2928252	—	—	—
NovaraF Refining the phenotype associated with MEF2C haploinsufficiency. Clin Genet 78, 471–477, doi:10.1111/j.1399-0004.2010.01413.x (2010).20412115	—	—	—
OkbayA Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nature genetics 48, 624–633, doi:10.1038/ng.3552 (2016).27089181PMC4884152	—	—	—
OkbayA Genome-wide association study identifies 74 loci associated with educational attainment. Nature 533, 539–542, doi:10.1038/nature17671 (2016).27225129PMC4883595	—	—	—
OliverPL Disruption of Visc-2, a Brain-Expressed Conserved Long Noncoding RNA, Does Not Elicit an Overt Anatomical or Behavioral Phenotype. Cereb Cortex 25, 3572–3585, doi:10.1093/cercor/bhu196 (2015).25209608PMC4585502	—	—	—
OrtalS The Role of Different Aspects of Impulsivity as Independent Risk Factors for Substance Use Disorders in Patients with ADHD: A Review. Curr Drug Abuse Rev 8, 119–133 (2015).2637385010.2174/1874473708666150916112913	—	—	—
OstergaardSD, DalsgaardS, FaraoneSV, Munk-OlsenT & LaursenTM Teenage Parenthood and Birth Rates for Individuals With and Without Attention-Deficit/Hyperactivity Disorder: A Nationwide Cohort Study. Journal of the American Academy of Child and Adolescent Psychiatry 56, 578–584 e573, doi:10.1016/j.jaac.2017.05.003 (2017).28647009	—	—	—
OwensJA A clinical overview of sleep and attention-deficit/hyperactivity disorder in children and adolescents. J Can Acad Child Adolesc Psychiatry 18, 92–102 (2009).19495429PMC2687494	—	—	—
PatelYM Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk. Cancer Res 76, 5768–5776, doi:10.1158/0008-5472.CAN-16-0446 (2016).27488534PMC5050097	—	—	—
PeyreH Relationship between early language skills and the development of inattention/hyperactivity symptoms during the preschool period: Results of the EDEN mother-child cohort. BMC psychiatry 16, 380, doi:10.1186/s12888-016-1091-3 (2016).27821161PMC5100106	—	—	—
PillingLC Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants. Aging (Albany NY) 8, 547–560, doi:10.18632/aging.100930 (2016).27015805PMC4833145	—	—	—
PolanczykG, de LimaMS, HortaBL, BiedermanJ & RohdeLA The worldwide prevalence of ADHD: a systematic review and metaregression analysis. The American journal of psychiatry 164, 942–948, doi:10.1176/ajp.2007.164.6.942 (2007).17541055	—	—	—
PriceAL Principal components analysis corrects for stratification in genome-wide association studies. Nature genetics 38, 904–909, doi:10.1038/ng1847 (2006).16862161	—	—	—
PurcellS PLINK: a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics 81, 559–575, doi:10.1086/519795 (2007).17701901PMC1950838	—	—	—
PurcellSM Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752, doi:10.1038/nature08185 (2009).19571811PMC3912837	—	—	—
QuX Identification, characterization, and functional study of the two novel human members of the semaphorin gene family. The Journal of biological chemistry 277, 35574–35585, doi:10.1074/jbc.M206451200 (2002).12110693	—	—	—
R Core Team. R: A language and environment for statistical computing., <http://www.r-project.org/> (2014).	—	—	—
RietveldCA Common genetic variants associated with cognitive performance identified using the proxy-phenotype method. Proceedings of the National Academy of Sciences of the United States of America 111, 13790–13794, doi:10.1073/pnas.1404623111 (2014).25201988PMC4183313	—	—	—
RietveldCA GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science 340, 1467–1471, doi:10.1126/science.1235488 (2013).23722424PMC3751588	—	—	—
Roadmap EpigenomicsC Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330, doi:10.1038/nature14248 (2015).25693563PMC4530010	—	—	—
RommelseNN, FrankeB, GeurtsHM, HartmanCA & BuitelaarJK Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. European child & adolescent psychiatry 19, 281–295, doi:10.1007/s00787-010-0092-x (2010).20148275PMC2839489	—	—	—
Schizophrenia Working Group of the Psychiatric Genomics, C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427, doi:10.1038/nature13595 (2014).25056061PMC4112379	—	—	—
SchreiweisC Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance. Proceedings of the National Academy of Sciences of the United States of America 111, 14253–14258, doi:10.1073/pnas.1414542111 (2014).25225386PMC4191787	—	—	—
ShunginD New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196, doi:10.1038/nature14132 (2015).25673412PMC4338562	—	—	—
SiaGM, ClemRL & HuganirRL The human language-associated gene SRPX2 regulates synapse formation and vocalization in mice. Science 342, 987–991, doi:10.1126/science.1245079 (2013).24179158PMC3903157	—	—	—
SniekersS Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence. Nature genetics 49, 1107–1112, doi:10.1038/ng.3869 (2017).28530673PMC5665562	—	—	—
SobreiraN, WalshMF, BatistaD & WangT Interstitial deletion 5q14.3-q21 associated with iris coloboma, hearing loss, dental anomaly, moderate intellectual disability, and attention deficit and hyperactivity disorder. Am J Med Genet A 149A, 2581–2583, doi:10.1002/ajmg.a.33079 (2009).19876902PMC5004776	—	—	—
SpeliotesEK Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature genetics 42, 937–948, doi:10.1038/ng.686 (2010).20935630PMC3014648	—	—	—
SpiteriE Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. American journal of human genetics 81, 1144–1157, doi:10.1086/522237 (2007).17999357PMC2276350	—	—	—
SubramanianA Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545–15550, doi:10.1073/pnas.0506580102 (2005).16199517PMC1239896	—	—	—
SudmantPH An integrated map of structural variation in 2,504 human genomes. Nature 526, 75–81, doi:10.1038/nature15394 (2015).26432246PMC4617611	—	—	—
TeslovichTM Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713, doi:10.1038/nature09270 (2010).20686565PMC3039276	—	—	—
Tobacco & Genetics, C. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nature genetics 42, 441–447, doi:10.1038/ng.571 (2010).20418890PMC2914600	—	—	—
TsuiD, VesseyJP, TomitaH, KaplanDR & MillerFD FoxP2 regulates neurogenesis during embryonic cortical development. The Journal of neuroscience : the official journal of the Society for Neuroscience 33, 244–258, doi:10.1523/JNEUROSCI.1665-12.2013 (2013).23283338PMC6618635	—	—	—
TurleyP MTAG: Multi-Trait Analysis of GWAS. bioRxiv, doi:10.1101/118810 (2017).	—	—	—
VernesSC Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS genetics 7, e1002145, doi:10.1371/journal.pgen.1002145 (2011).21765815PMC3131290	—	—	—
VolkowND Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. The Journal of neuroscience : the official journal of the Society for Neuroscience 21, RC121 (2001).10.1523/JNEUROSCI.21-02-j0001.2001PMC676380511160455	—	—	—
VolkowND, FowlerJS, WangG, DingY & GatleySJ Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord 6 Suppl 1, S31–43 (2002).1268551710.1177/070674370200601s05	—	—	—
WangY Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nature genetics 46, 736–741, doi:10.1038/ng.3002 (2014).24880342PMC4074058	—	—	—
Wellcome Trust Case Control, C. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nature genetics 44, 1294–1301, doi:10.1038/ng.2435 (2012).23104008PMC3791416	—	—	—
WillerCJ, LiY & AbecasisGR METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191, doi:10.1093/bioinformatics/btq340 (2010).20616382PMC2922887	—	—	—
WinklerTW Quality control and conduct of genome-wide association meta-analyses. Nat. Protocols 9, 1192–1212, doi:10.1038/nprot.2014.071 (2014).24762786PMC4083217	—	—	—
WonH Chromosome conformation elucidates regulatory relationships in developing human brain. Nature 538, 523–527, doi:10.1038/nature19847 (2016).27760116PMC5358922	—	—	—
WrayNR & SullivanPF Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. bioRxiv, doi:10.1101/167577 (2017).PMC593432629700475	—	—	—
YangJ, LeeSH, GoddardME & VisscherPM GCTA: a tool for genome-wide complex trait analysis. American journal of human genetics 88, 76–82, doi:10.1016/j.ajhg.2010.11.011 (2011).21167468PMC3014363	—	—	—
YangL Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 162B, 419–430, doi:10.1002/ajmg.b.32169 (2013).PMC432178923728934	—	—	—
YatesF Contingency Tables Involving Small Numbers and the χ2 Test. Supplement to the Journal of the Royal Statistical Society 1, 217–235, doi:10.2307/2983604 (1934).	—	—	—
ZayatsT Genome-wide analysis of attention deficit hyperactivity disorder in Norway. PloS one 10, e0122501, doi:10.1371/journal.pone.0122501 (2015).25875332PMC4395400	—	—	—
ZhengJ LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272–279, doi:10.1093/bioinformatics/btw613 (2017).27663502PMC5542030	—	—	—
ZhernakovaDV Identification of context-dependent expression quantitative trait loci in whole blood. Nature genetics 49, 139–145, doi:10.1038/ng.3737 (2017).27918533	—	—	—

In this knowledge base

Title	Year	PMID
Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.	2025	40360802
Guidelines for Evaluating the Comparability of Down-Sampled GWAS Summary Statistics.	2023	37713023
A large-scale genome-wide association study meta-analysis of cannabis use disorder.	2020	33096046
Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations.	2019	30940813
International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci.	2019	31594949
A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder.	2018	29325848

External

Title	Authors	Journal	Year	Link
ADHD polygenic risk predicts neural signatures of cognitive control: Evidence from midfrontal theta dynamics.	Aydin Ü et al.	—	2026	→
A diffusion MRI-derived perivascular metric related to glymphatic-associated processes in bipolar disorder vulnerability: Multimodal correlates across emotion dysregulation patients and offspring.	Pascucci A et al.	—	2026	→
Adult ADHD with comorbid major depression shows a distinguishable polygenic pattern and negative cognitive style.	Kranz TM et al.	—	2026	→
A single-cell spatiotemporal transcriptomic atlas of mouse prefrontal cortex maps dynamics of intratelencephalic neurons during postnatal development.	Zheng H et al.	—	2026	→
Association between genetic polymorphisms in circadian cycle genes (<i>PER2, PER3</i>, and <i>HCRTR2</i>) and Attention Deficit Hyperactivity Disorder (ADHD).	Alves RB et al.	—	2026	→
Characterization of the chromosome 7 locus associated with suicidal behavior.	Fiori LM et al.	—	2026	→
Convergent genetic pathways linking neuropsychiatric and ocular disorders in children.	Pan M et al.	—	2026	→
Developmental convergence and divergence in human stem cell models of autism.	Gordon A et al.	—	2026	→
Developmental trajectories of glutamate and the variable clinical course of ADHD in youth.	Bouyssi-Kobar M et al.	—	2026	→
Disorder-Specific Genetic Effects Drive the Associations Between Psychopathology and Cognitive Functioning.	Liao W et al.	—	2026	→
Genetic alternative splicing regulation mapping of cartilage and synovium reveals tissue-specific mechanisms of joint-related traits.	Tian W et al.	—	2026	→
Genetic correlates of self-harm hospitalization: Insights from polygenic scores in the Taiwan Biobank.	Hsu YC et al.	—	2026	→
Genetic liability to mental disorders and being delivered via cesarean section.	Østergaard SD et al.	—	2026	→
Genetic studies of psychosocial disability establish correlations and causal relationships with neuropsychiatric disorders.	Doherty E et al.	—	2026	→
Genome-wide identification and characterization of QTLs for transcriptional noise in human midbrain cells.	Hirose N et al.	—	2026	→
Impact of SNAP-25 MnlI polymorphism on brain activity patterns in children with ADHD: Insights from fractional amplitude of low-frequency fluctuation analysis.	Fang D et al.	—	2026	→
Interplay between attention-deficit/hyperactivity disorder, educational attainment, and vascular risk factors: Insights from Mendelian randomization analyses.	Song J et al.	—	2026	→
Limbic System White Matter in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Longitudinal Diffusion Magnetic Resonance Imaging Analysis.	Connaughton M et al.	—	2026	→
Maternal Attention Deficit Hyperactivity Disorder and Perinatal Depression: A Systematic Review.	Pierotti N et al.	—	2026	→
Metabolomic Profile in Children and Adolescents with Attention Deficit Hyperactivity Disorders.	Yadav BK et al.	—	2026	→
Multivariate genetic analyses of 2.2 million individuals reveal broad and substance-specific pathways of addiction risk.	Poore HE et al.	—	2026	→
Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause.	Wynchank D et al.	—	2026	→
Pink Noise and a Pure Tone Both Reduce 1/<i>f</i> Neural Noise in Adults With Elevated ADHD Traits: A Critical Appraisal of the Moderate Brain Arousal Model.	Rijmen J et al.	—	2026	→
Polygenic scores for psychiatric traits mediate the impact of multigenerational history for depression on offspring psychopathology.	Lee E et al.	—	2026	→
Prenatal and postnatal effects of gestational immune activation on synaptic and neurodevelopmental pathways via epigenetic mechanisms.	Zhu B et al.	—	2026	→
Rare genetic variants confer a high risk of ADHD and implicate neuronal biology.	Demontis D et al.	—	2026	→
Sex Differences in Brain Cell Type-Specific Chromatin Accessibility in Schizophrenia.	Ma Y et al.	—	2026	→
"SHANK3 deficiency alters early progenitor dynamics and reveals shared pathways with neurodegeneration".	Varella-Branco E et al.	—	2026	→
Spatiotemporal brain transcriptomics reveal risk gene hot-spots in major neuropsychiatric disorders.	Liu W et al.	—	2026	→
Systematic Review: Convergence and Divergence Between Autism Spectrum Disorder and Obsessive-Compulsive Disorder: Genetic, Neuroimaging, and Cognitive Findings.	Pereira JA et al.	—	2026	→
The dynamic nature of genetic risk for schizophrenia within genes regulated by FOXP1 during neurodevelopment.	Ali D et al.	—	2026	→
The genetic architecture of human cerebellar morphology supports a key role for the cerebellum in human evolution and psychopathology.	Moberget T et al.	—	2026	→
Transcriptomic and phenotypic convergence of neurodevelopmental disorder risk genes in vitro and in vivo.	Fernandez Garcia M et al.	—	2026	→
Abnormal Association Between Neural Activity and Genetic Expressions of Impulsivity in Attention-Deficit/Hyperactivity Disorder: An Adolescent Brain Cognitive Development Study.	Jeon S et al.	—	2025	→
ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives.	Bogdańska-Chomczyk E et al.	—	2025	→
ADHD remote technology and ADHD transition: predicting and preventing negative outcomes (ART-transition) - an adolescent prospective cohort study protocol.	Bowler A et al.	—	2025	→
A narrative review of research advances in gut microbiota and microecological agents in children with attention deficit hyperactivity disorder (ADHD).	Liu Y et al.	—	2025	→
A Neuroaffirmative, Self-Determination Theory-Based Psychosocial Intervention for Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Feasibility Study.	Champ RE et al.	—	2025	→
Antisocial personality disorder:Failure to balance excitation/inhibition?	Lesch KP et al.	—	2025	→
Artificial intelligence for children with attention deficit/hyperactivity disorder: a scoping review.	Sun B et al.	—	2025	→
Assessing the Causal Relationship Between Various Immune Cells and Attention Deficit Hyperactivity Disorder: Mendelian Randomization Study.	Ge Q et al.	—	2025	→
Association Between ADHD and Pediatric Asthma: Results From a Large-Sample Cross-Sectional Study of National Surveys and Mendelian Randomization Analyses.	Zhuoran Z et al.	—	2025	→
Association between aggression and ADHD polygenic scores and school-age aggression: the mediating role of preschool externalizing behaviors and adverse experiences.	Bouliane M et al.	—	2025	→
Association between antidiabetic drug targets and psychiatric disorders.	Yuan R et al.	—	2025	→
Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis.	Ng RWY et al.	—	2025	→
Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder.	Bäckman J et al.	—	2025	→
Associations of polygenic risk scores differentiating attention-deficit hyperactivity disorder from autism spectrum disorder with cognitive and cortical alterations in Schizophrenia patients.	Kuramitsu A et al.	—	2025	→
Atlas of Proteomic signatures of brain structure and its links to brain disorders.	Ren P et al.	—	2025	→
Attention-Deficit/Hyperactivity Disorder Symptoms Are Common and Associated with Worse Glycemic Control in Adults with Type 1 Diabetes.	Zhang-James Y et al.	—	2025	→
A western dietary pattern during pregnancy is associated with neurodevelopmental disorders in childhood and adolescence.	Horner D et al.	—	2025	→
Behavioural, immunological and transcriptomic consequences of post-weaning social isolation and chronic celecoxib administration in mouse.	Laighneach A et al.	—	2025	→
Brain region and cell type-specific DNA methylation profiles in association with ADHD.	Meijer M et al.	—	2025	→
Causal Impacts of Psychiatric Disorders on Cognition and the Mediating Effect of Oxidative Stress: A Mendelian Randomization Study.	Gao Y et al.	—	2025	→
Causality Between ADHD, ASD, and CVDs: A Two-Step, Two-Sample Mendelian Randomization Investigation.	Zheng Z et al.	—	2025	→
Causal relationship between attention deficit hyperactivity disorder and atherosclerosis: A bidirectional Mendelian randomization study.	Hu XY et al.	—	2025	→
Causal Relationships Between Retinal Diseases and Psychiatric Disorders Have Implications for Precision Psychiatry.	Zhang Z et al.	—	2025	→
Cell type-specific methylome-wide association studies of childhood ADHD symptoms.	Meijer M et al.	—	2025	→
Child maltreatment as a transdiagnostic risk factor for the externalizing dimension: a Mendelian randomization study.	Konzok J et al.	—	2025	→
Chromatin accessibility during human first-trimester neurodevelopment.	Mannens CCA et al.	—	2025	→
Circulating MicroRNAs in Cord Blood to Predict Attention-Deficit/Hyperactivity Disorder Diagnosis.	Dypås LB et al.	—	2025	→
Cognitive Impairment in Adult Attention Deficit Hyperactivity Disorder: Clinical Implications and Novel Treatment Strategies.	Vega AJ et al.	—	2025	→
Common and rare genetic variants explain distinct diagnostic variance in pediatric attention deficit hyperactivity disorder.	Arnett AB et al.	—	2025	→
Common and rare variant analyses implicate late-infancy cerebellar development and immune genes in ADHD.	Zhong Y et al.	—	2025	→
Comorbidity of attention deficit hyperactivity disorder in young adults who had major depressive disorder.	Yazıcı M et al.	—	2025	→
Comparative Analysis of Phenotypic and Genotypic Differences Between Individuals Affected by Regressive and Non-Regressive Autism: A Cross-Sectional Study.	Tonekaboni SH et al.	—	2025	→
Copy number variations in the Brazilian High-Risk Cohort for Mental Conditions.	Arendt J et al.	—	2025	→
Cross-Sectional Brain Age Assessments Are Limited in Predicting Future Brain Change.	Korbmacher M et al.	—	2025	→
Deep adversarial learning identifies ADHD-specific associations between apoptotic genes and white matter microstructure in frontal-striatum-cerebellum circuit.	Zhao Y et al.	—	2025	→
Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations.	Liu JJ et al.	—	2025	→
Disruption of gut microbiome and metabolome in treatment-naïve children with attention deficit hyperactivity disorder.	Han D et al.	—	2025	→
Dissecting causal relationships between cortical morphology and neuropsychiatric disorders: a bidirectional Mendelian randomization study.	Lin BD et al.	—	2025	→
Dissociable genetic influences on eye movements during abstract versus naturalistic social scene viewing in infancy.	Portugal AM et al.	—	2025	→
Do specific myelin autoantibodies and increased cerebral dopamine neurotrophic factor in the context of inflammation predict the diagnosis of attention deficit hyperactivity disorder in medication-free children?	Tezcan ME et al.	—	2025	→
Early developmental origins of cortical disorders modeled in human neural stem cells.	Mato-Blanco X et al.	—	2025	→
Early establishment and life course stability of sex biases in the human brain transcriptome.	Benoit-Pilven C et al.	—	2025	→
Early life adversity and adult attention-deficit/hyperactivity disorder (ADHD): Pathways to persistence and adult susceptibility.	Zou P et al.	—	2025	→
Effect of Parental-Child Age Gaps and Skipped-Generation Families on Comorbidities Related to Attention Deficit Hyperactivity Disorder: A Population-Based Case-Control Study.	Fan HC et al.	—	2025	→
Efficacy and Safety of a Probiotic Mixture Containing Bifidobacterium animalis subsp. lactis BLa80 and Lacticaseibacillus rhamnosus LRa05 in Children With Attention-Deficit/Hyperactivity Disorder.	Niu Q et al.	—	2025	→
Elucidating neuroepigenetic mechanisms to inform targeted therapeutics for brain disorders.	Weekley BH et al.	—	2025	→
Enhancing the discriminatory power of polygenic scores for ADHD and autism in clinical and non-clinical samples.	Li JJ et al.	—	2025	→
Epigenetic age across development in children and adolescents with ADHD.	Wrigglesworth J et al.	—	2025	→
Estimating effects of serum vitamin B12 levels on psychiatric disorders and cognitive impairment: a Mendelian randomization study.	Lu T et al.	—	2025	→
Evaluating the Causal Effects of ADHD and Autism on Cardiovascular Diseases and Vice Versa: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies.	Ryszkiewicz P et al.	—	2025	→
Excess Wnt in neurological disease.	Pascual DM et al.	—	2025	→
Exon-variant interplay and multi-modal evidence identify endocrine dysregulation in severe psychiatric disorders impacting excitatory neurons.	Worf K et al.	—	2025	→
Exploring the genetic architecture of brain structure and ADHD using polygenic neuroimaging-derived scores.	van der Es T et al.	—	2025	→
Exploring the shared genetic basis of attention-deficit/hyperactivity disorder and obstructive sleep apnea: A multi-omics analysis.	Huang Y et al.	—	2025	→
Expression profile of the ADHD risk gene <i>ADGRL3</i> during human neurodevelopment and the effects of genetic variation.	McNeill RV et al.	—	2025	→
FOXP2-immunoreactive corticothalamic neurons in neocortical layers 6a and 6b are tightly regulated by neuromodulatory systems.	Qi G et al.	—	2025	→
Gene-environment interaction in ADHD traits: the role of school environment, personality, callousness-unemotional traits and satisfaction with life.	Schwabe I et al.	—	2025	→
Genetic and environmental contributions to individual differences in visual attention and oculomotor control in early infancy.	Siqueiros-Sanchez M et al.	—	2025	→
Genetic and Environmental Effects on Parent-Rated Adaptive Behaviour in Infancy.	Halkola H et al.	—	2025	→
Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M Subjects.	Lewandrowski KU et al.	—	2025	→
Genetic architecture of RNA editing, splicing and gene expression in schizophrenia.	Choudhury M et al.	—	2025	→
Genetic associations between orexin genes and phenotypes related to behavioral regulation in humans, including substance use.	Aliev F et al.	—	2025	→
Genetic Confounding of the Association Between Age at First Hormonal Contraception and Depression.	Mundy J et al.	—	2025	→
Genetic Correlates of Treatment-Resistant Depression.	Xu B et al.	—	2025	→
Genetic Etiology Link to Brain Function Underlying ADHD Symptoms and its Interaction with Sleep Disturbance: An ABCD Study.	Feng A et al.	—	2025	→
Genetic Interplay Between Attention-Deficit/Hyperactivity Disorder and Pain Suggests Neurodevelopmental Pathways and Comorbidity Risk.	Ciochetti NP et al.	—	2025	→
Genetic overlap between household income and psychiatric disorders.	Zhang J et al.	—	2025	→
Genetic predisposition for negative affect predicts mental health burden during the COVID-19 pandemic.	Schowe AM et al.	—	2025	→
Genetic risk predicts adolescent mood pathology via sexual differentiation of brain function and physiological aging.	Petrican R et al.	—	2025	→
Genetics of Tourette Syndrome.	Fernandez TV	—	2025	→
Genome data based deep learning identified new genes predicting pharmacological treatment response of attention deficit hyperactivity disorder.	Zhao Y et al.	—	2025	→
Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.	Strom NI et al.	—	2025	→
Genome-wide association meta-analysis and rare copy number variant analysis of treatment-resistant depression.	Xiong Y et al.	—	2025	→
Genome-wide association meta-analysis of childhood ADHD symptoms and diagnosis identifies new loci and potential effector genes.	van der Laan CM et al.	—	2025	→
Genome-wide association study unravels mechanisms of brain glymphatic activity.	Huang SY et al.	—	2025	→
Genomic Analysis of Trichotillomania.	Halvorsen MW et al.	—	2025	→
Genomics-driven integrative analysis highlights immune-related plasma proteins for psychiatric disorders.	Gong W et al.	—	2025	→
Global trends in physical activity research of attention-deficit/hyperactivity disorder: A scientometric study (2000-2024).	Li D et al.	—	2025	→
Glutamate imbalance in key structure of the default mode network in adults with attention-deficit/hyperactivity disorder.	Vidor MV et al.	—	2025	→
High level of immunoglobulin G targeting mycoplasma or cytomegalovirus in the newborn increases risk of ADHD.	Borbye-Lorenzen N et al.	—	2025	→
Human-like associations between gut microbiome composition and inattention, hyperactivity, and impulsivity in dogs.	Salamon A et al.	—	2025	→
Hypothalamic-pituitary-adrenal axis dysfunction in children with ADHD: A systematic review and meta-analysis.	Fulun L et al.	—	2025	→
Identification of Risk Genes for Attention-Deficit/Hyperactivity Disorder During Early Human Brain Development.	Deng MG et al.	—	2025	→
Identification of specific brain cell types associated with the interplay between inflammatory bowel diseases and neuropsychiatric disorders by Cell-Stratified Mendelian Randomisation.	Zhou Q et al.	—	2025	→
Identifying novel chemical-related susceptibility genes for five psychiatric disorders through integrating genome-wide association study and tissue-specific 3'aQTL annotation datasets.	Shi S et al.	—	2025	→
Immune-Developmental Processes Contribute to Schizophrenia Risk: Insights From a Genetic Overlap Study With Height.	Romero C et al.	—	2025	→
Implications of gene × environment interactions in post-traumatic stress disorder risk and treatment.	Seah C et al.	—	2025	→
Improving Machine Learning Prediction of ADHD Using Gene Set Polygenic Risk Scores and Risk Scores From Genetically Correlated Phenotypes.	Barnett EJ et al.	—	2025	→
Integrating brain imaging features and genomic profiles for the subtyping of major depression.	Yin L et al.	—	2025	→
Integrative analysis of cerebrospinal fluid biomarkers, metabolomics, and polygenic risk reveals novel metabolite associations with Alzheimer's disease.	Francia M et al.	—	2025	→
Integrative genetic analysis: cornerstone of precision psychiatry.	Vorstman J et al.	—	2025	→
Integrative Mendelian randomization for detecting exposure-by-group interactions using group-specific and combined summary statistics.	Xu K et al.	—	2025	→
Integrative multi-omics data from early development to identify the genes and cell types underlying attention-deficit/hyperactivity disorder.	Jiao S et al.	—	2025	→
Intergenerational transmission of polygenic predisposition for neuropsychiatric traits on emotional and behavioural difficulties in childhood.	Allegrini AG et al.	—	2025	→
In the genetics of the beholder: gene-environment interplay for internalising and externalising behaviours using polygenic scores and adolescent perceptions of parenting.	Rainy NR et al.	—	2025	→
Investigating Gene-Environment Interplay Between Bereavement and Polygenic Risk for Attention-Deficit/Hyperactivity Disorder on Externalizing Behaviors During Adolescence.	Espinosa Dice AL et al.	—	2025	→
Investigating the causal relationships between attention-deficit/hyperactivity disorder and autoimmune diseases: Evidence from Mendelian randomization study.	Zhou Y et al.	—	2025	→
Investigating the increased risk of schizophrenia and bipolar disorders in relatives of ADHD probands using colocalization analysis of common genetic variants.	Peyre H et al.	—	2025	→
Investigation of brain structures and potential mechanisms associated with ADHD: Insights from Mendelian randomization and genetic analysis.	Hu X et al.	—	2025	→
iPSCs and iPSC-derived cells as a model of human genetic and epigenetic variation.	Quaid K et al.	—	2025	→
Joint contribution of polygenic scores for depression and attention-deficit/hyperactivity disorder to youth suicidal ideation and attempt.	Orri M et al.	—	2025	→
Large-scale evidence of a general disease ('<i>d</i>') factor accounting for both mental and physical health disorders in different age groups.	Sun H et al.	—	2025	→
Limbic-Sensorimotor Tug of War for the Hippocampus: Dynamic Functional Connectivity as a Transdiagnostic Vulnerability Marker in Offspring of Patients With Emotion Dysregulation.	Saccaro LF et al.	—	2025	→
Linking Genome-Wide Association Studies to Pharmacological Treatments for Psychiatric Disorders.	Arnatkeviciute A et al.	—	2025	→
Mapping associations of polygenic scores with autistic and ADHD traits in a single city region.	Reed ZE et al.	—	2025	→
Mapping the cellular etiology of schizophrenia and complex brain phenotypes.	Duncan LE et al.	—	2025	→
Mapping the Genetic Landscape of Psychiatric Disorders With the MiXeR Toolset.	van der Meer D et al.	—	2025	→
Mapping the microRNA landscape in the older adult brain and its genetic contribution to neuropsychiatric conditions.	Vattathil SM et al.	—	2025	→
Maternal stress, cord blood zinc and attention deficit hyperactivity disorder.	Takahashi N et al.	—	2025	→
Meta-Analysis: Parenting Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Compared to Healthy Controls.	Văidean T et al.	—	2025	→
Modelling Neural Disorders with the <i>D. melanogaster</i> Larval Peripheral and Adult Dopaminergic Systems.	Tendero-Lopez D et al.	—	2025	→
Multitrait Analysis to Decipher the Intertwined Genetic Architecture of Neuroanatomical Phenotypes and Psychiatric Disorders.	Auvergne A et al.	—	2025	→
Multivariate genome-wide analysis reveals shared genetic architecture and brain structural correlates of human cognitive abilities.	Chen H et al.	—	2025	→
Neuroimaging genetics and developmental psychopathology: A systematic review.	Cheek CL et al.	—	2025	→
New developments and potential future research directions in adult ADHD.	Kooij JJS	—	2025	→
NHE9 and Endosomal pH: Converging Mechanisms in Neurodevelopmental, Psychiatric and Neurodegenerative Disorders.	Prasad H	—	2025	→
Observer-rated environmental sensitivity and its characterization at behavioral, genetic, and physiological levels.	Weyn S et al.	—	2025	→
Patterns of shared genetic risk between chronic pain, psychopathologies, and neuroticism.	Zorina-Lichtenwalter K et al.	—	2025	→
Perimenopausal symptoms in women with and without ADHD: A population-based cohort study.	Jakobsdóttir Smári U et al.	—	2025	→
Polygenic architecture of brain structure and function, behaviors, and psychopathologies in children.	Joo YY et al.	—	2025	→
Polygenic overlap between subjective well-being and psychiatric disorders and cross-ancestry validation.	Jung JY et al.	—	2025	→
Polygenic prediction of occupational status GWAS elucidates genetic and environmental interplay in intergenerational transmission, careers and health in UK Biobank.	Akimova ET et al.	—	2025	→
Polygenic risk scores for severe psychiatric disorders in bipolar disorders: associations with the clinical and dimensional expression, interactions with childhood maltreatment and mediation models.	Etain B et al.	—	2025	→
Polygenic risk scores in relation to suicidality among youth with or at risk for bipolar disorder.	Zai CC et al.	—	2025	→
Polygenic scores and antidepressant treatment outcomes in major depression: a critical integrative review.	Serretti A et al.	—	2025	→
Polygenic scores and symptom severity change after internet-delivered cognitive behaviour therapy for depression and anxiety.	Bäckman J et al.	—	2025	→
Potential Genetic Intersections Between ADHD and Alzheimer's Disease: A Systematic Review.	Borgonovo R et al.	—	2025	→
Potentially causal associations between placental DNA methylation and schizophrenia and other neuropsychiatric disorders.	Cilleros-Portet A et al.	—	2025	→
Practical tools for female-specific ADHD: The impact of hormonal fluctuations in clinical practice and from the literature.	Wynchank D et al.	—	2025	→
Precision Medicine in Pediatric Attention-deficit/Hyperactivity Disorder: A Systematic Review of Behavioral, Neurobiological and Genetic Diagnostic Biomarkers.	Pranjić M et al.	—	2025	→
Prenatal and childhood exposure to mixtures of environmental chemicals and adolescence attentional problems: a triangulation study.	Fabbri L et al.	—	2025	→
Prenatal maternal stress: triangulating evidence for intrauterine exposure effects on birth and early childhood outcomes across multiple approaches.	Lund IO et al.	—	2025	→
Prevalence and correlates of common mental disorders among participants of the Uganda Genome Resource: Opportunities for psychiatric genetics research.	Kalungi A et al.	—	2025	→
Proteome-wide association studies have predicted that the protein abundance of LSM6, GMPPB, ICA1L, and CISD2 is associated with attention-deficit/hyperactivity disorder.	Liu J	—	2025	→
Psychiatric genome-wide association study enrichment shows promise for future psychopharmaceutical discoveries.	Hatoum AS et al.	—	2025	→
Psychological, social factors, and smoking behavior mediated the effects of cannabis use on personality disorders: A Mendelian randomization study.	Ni Y et al.	—	2025	→
PTPRD pleiotropy, genetically driven childbirth timing, and corpus callosum microstructure as potential mechanisms underlying ADHD-RLS comorbidity.	Li FJ et al.	—	2025	→
Putative epicenters identified by transcriptome-neuromorphic interactions in attention-deficit/hyperactivity disorder biotypes.	Tang Q et al.	—	2025	→
Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypes.	Reus LM et al.	—	2025	→
[Relationship between polygenic risk scores for various psychiatric disorders and clinical and neuropsychological characteristics in children with attention-deficit/hyperactivity disorder].	Wu ZM et al.	—	2025	→
Research advances and future directions in female ADHD: the lifelong interplay of hormonal fluctuations with mood, cognition, and disease.	Kooij JJS et al.	—	2025	→
Research progress of tDCS in the treatment of ADHD.	Huang R et al.	—	2025	→
Review: Child Psychiatry in the Era of Genomics: The Promise of Translational Genetics Research for the Clinic.	Fitzpatrick SE et al.	—	2025	→
Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies.	Solomon MB et al.	—	2025	→
Serum levels of fat-soluble vitamins in children with attention deficit hyperactivity disorder and relationship with symptom subtypes.	Li M et al.	—	2025	→
SETD1A regulates psychiatric gene networks involved in genomic stability and synaptic function in rare and sporadic schizophrenia.	Sawada T et al.	—	2025	→
Sex differences in self-reported attention-deficit/hyperactivity disorder symptoms in clinical and population-based cohorts.	Solberg BS et al.	—	2025	→
Shared biological pathways linking ADHD and cortisol variability are related to externalizing behaviors.	Ramos JKN et al.	—	2025	→
Shared Genetic Architecture Between Psychiatric Disorders and Keratoconus: Insights From a Large-Scale Genome-Wide Cross-Trait Analysis.	Li G et al.	—	2025	→
Signaling by latrophilin adhesion-GPCRs in synapse assembly.	Südhof TC	—	2025	→
Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression.	Chawla A et al.	—	2025	→
Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK Biobank.	Kamp M et al.	—	2025	→
Spatiotemporal 3D chromatin organization across multiple brain regions during human fetal development.	Sun Y et al.	—	2025	→
Spousal correlations for nine psychiatric disorders are consistent across cultures and persistent over generations.	Fan CC et al.	—	2025	→
The effects of adolescent depression and attention-deficit/hyperactivity disorder on educational attainment in adulthood.	Chen J et al.	—	2025	→
The Genetic Architecture of Differentiating Behavioral and Emotional Problems in Early Life.	Askelund AD et al.	—	2025	→
The left amygdala is genetically sexually-dimorphic: multi-omics analysis of structural MRI volumes.	Gui Y et al.	—	2025	→
The Lung-Brain Axis: Genetic Evidence for Causal Effects of Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis on Brain Structure.	Guo T et al.	—	2025	→
The regulatory variant rs1950834 confers the risk of depressive disorder by reducing LRFN5 expression.	Luan D et al.	—	2025	→
The relationship between major depression, attention-deficit hyperactivity disorder and coronary artery disease: A two-sample Mendelian randomization analysis.	Zhang X et al.	—	2025	→
The role of co-occurring conditions and genetics in the associations of eating disorders with attention-deficit/hyperactivity disorder and autism spectrum disorder.	Christiansen GB et al.	—	2025	→
The Role of Mitochondrial DNA Copy Number in Neurodevelopmental Disorders: A Bidirectional Two-Sample Mendelian Randomization Study.	Qiu X et al.	—	2025	→
Transcriptional and epigenetic targets of MEF2C in human microglia contribute to cellular functions related to autism risk and age-related disease.	Nguyen C et al.	—	2025	→
Transcriptomic Dysregulation in Animal Models of Attention-Deficit Hyperactivity Disorder and Nicotine Dependence Suggests Shared Neural Mechanisms.	Van Horn S et al.	—	2025	→
Transdiagnostic and Diagnosis-Specific Morphological Similarity Related Transcriptional Profile in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.	Zhang F et al.	—	2025	→
Transdiagnostic neuroanatomical risk in schizophrenia: integrating regional vulnerability indices with anthropometric and fitness-based markers of cardiometabolic health.	Rößler H et al.	—	2025	→
Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies-A Narrative Review.	Capatina TF et al.	—	2025	→
Unraveling ADHD: genes, co-occurring traits, and developmental dynamics.	Miller CJ et al.	—	2025	→
Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment.	Poddar A et al.	—	2025	→
Unraveling the phenotypic expression of ADHD symptoms in middle- and older-aged adults: insights from confirmatory factor analysis of the US Health and Retirement Study.	Levine SZ et al.	—	2025	→
Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records.	Þorsteinsson H et al.	—	2025	→
White matter microstructure links with brain, bodily and genetic attributes in adolescence, mid- and late life.	Korbmacher M et al.	—	2025	→
Writing the Engram: Epigenetic Mechanisms of Memory Allocation.	Tarulli I et al.	—	2025	→
Abundant pleiotropy across neuroimaging modalities identified through a multivariate genome-wide association study.	Tissink EP et al.	—	2024	→
A concerted neuron-astrocyte program declines in ageing and schizophrenia.	Ling E et al.	—	2024	→
Activity-Dependent Transcriptional Program in NGN2+ Neurons Enriched for Genetic Risk for Brain-Related Disorders.	Ma Y et al.	—	2024	→
Adenosinergic system and nucleoside transporters in attention deficit hyperactivity disorder: Current findings.	Valladão SC et al.	—	2024	→
Adult ADHD: it is old and new at the same time - what is it?	Custodio RJP et al.	—	2024	→
Advances in the etiology and neuroimaging of children with attention deficit hyperactivity disorder.	Shen F et al.	—	2024	→
A GWAS for grip strength in cohorts of children-Advantages of analysing young participants for this trait.	Abbondanza F et al.	—	2024	→
Alcohol milestones and internalizing, externalizing, and executive function: longitudinal and polygenic score associations.	Paul SE et al.	—	2024	→
Allele-specific transcription factor binding across human brain regions offers mechanistic insight into eQTLs.	Anderson AG et al.	—	2024	→
A multi-ancestry cerebral cortex transcriptome-wide association study identifies genes associated with smoking behaviors.	Tan Q et al.	—	2024	→
A multi-regional human brain atlas of chromatin accessibility and gene expression facilitates promoter-isoform resolution genetic fine-mapping.	Dong P et al.	—	2024	→
An evolutionary perspective on complex neuropsychiatric disease.	McClellan JM et al.	—	2024	→
An investigation on the alterations in Wnt signaling in ADHD across developmental stages.	Walter NM et al.	—	2024	→
Assessing the validity of a self-reported clinical diagnosis of schizophrenia.	Woolway GE et al.	—	2024	→
Association between blood mitochondrial DNA copy number and mental disorders: A bidirectional two-sample mendelian randomization study.	Lu Y et al.	—	2024	→
Association of congenital heart disease and neurodevelopmental disorders: an observational and Mendelian randomization study.	Liu ZY et al.	—	2024	→
Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder.	Jonsson L et al.	—	2024	→
Associations between attention-deficit hyperactivity disorder genetic liability and ICD-10 medical conditions in adults: utilizing electronic health records in a Phenome-Wide Association Study.	Haan E et al.	—	2024	→
Associations between breakfast skipping and outcomes in neuropsychiatric disorders, cognitive performance, and frailty: a Mendelian randomization study.	Zhang Z et al.	—	2024	→
Associations between sleep problems in children with ADHD and parental insomnia and ADHD symptoms.	Bondopandhyay U et al.	—	2024	→
A state-of-the-art overview of candidate diagnostic biomarkers for Attention-deficit/hyperactivity disorder (ADHD).	Parlatini V et al.	—	2024	→
Attachment Styles and Parenting Attitudes in Adults With "Pseudo-Attention-Deficit/Hyperactivity Disorder".	Sawamura Y et al.	—	2024	→
Attention deficit and hyperactivity disorder and use of psychostimulants in Aotearoa, New Zealand: exploring the treatment gap.	Lillis S	—	2024	→
Attention-deficit/hyperactivity disorder.	Faraone SV et al.	—	2024	→
Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: Evidence From Multiple Genetically Informed Designs.	Garcia-Argibay M et al.	—	2024	→
Attention-Deficit/Hyperactivity Disorder as a Potential Risk Factor for Dementia and Other Neurocognitive Disorders: A Systematic Review.	Carr RH et al.	—	2024	→
Attitudes of parents of children with ADHD towards genetic testing: Data from a Turkish sample.	Beyazit U et al.	—	2024	→
Blood metabolites, neurocognition and psychiatric disorders: a Mendelian randomization analysis to investigate causal pathways.	Guo J et al.	—	2024	→
Causal effect of systemic lupus erythematosus on psychiatric disorders: A two-sample Mendelian randomization study.	Xue H et al.	—	2024	→
Causal Relationship between Attention-Deficit Hyperactivity Disorder and Autism Spectrum Disorder: A Two-Sample Mendelian Randomization.	Jiang Z et al.	—	2024	→
Causal relationships between atopic dermatitis and psychiatric disorders: a bidirectional two-sample Mendelian randomization study.	Cao S et al.	—	2024	→
Cell-type deconvolution of bulk-blood RNA-seq reveals biological insights into neuropsychiatric disorders.	Boltz T et al.	—	2024	→
Cerebellar network alterations in adult attention-deficit/hyperactivity disorder.	Parkkinen S et al.	—	2024	→
Changes in sleep patterns in people with a history of depression during the COVID-19 pandemic: a natural experiment.	Shin M et al.	—	2024	→
Characterization of Gene Regulatory Elements in Human Fetal Cortical Development: Enhancing Our Understanding of Neurodevelopmental Disorders and Evolution.	Guo Q et al.	—	2024	→
Childhood correlates and young adult outcomes of trajectories of emotional problems from childhood to adolescence.	Tseliou F et al.	—	2024	→
Childhood Physical Health and Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Modifiable Factors.	So M et al.	—	2024	→
Clinical characteristics of probands with obsessive-compulsive disorder from simplex and multiplex families.	Lima MO et al.	—	2024	→
Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation.	van der Meer D et al.	—	2024	→
Connecting clinical and genetic heterogeneity in ADHD.	Yap CX et al.	—	2024	→
Cortico-striatal differences in the epigenome in attention-deficit/ hyperactivity disorder.	Shastri GG et al.	—	2024	→
Criminal convictions in males and females diagnosed with attention deficit hyperactivity disorder: A Swedish national registry study.	Ångström AK et al.	—	2024	→
Cross-ancestry atlas of gene, isoform, and splicing regulation in the developing human brain.	Wen C et al.	—	2024	→
Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking.	Johnson EC et al.	—	2024	→
Cumulative Effects of Resting-State Connectivity Across All Brain Networks Significantly Correlate with Attention-Deficit Hyperactivity Disorder Symptoms.	Mooney MA et al.	—	2024	→
Deciphering the Role of Rapidly Evolving Conserved Elements in Primate Brain Development and Exploring Their Potential Involvement in Alzheimer's Disease.	Hu B et al.	—	2024	→
Developmental origins of psycho-cardiometabolic multimorbidity in adolescence and their underlying pathways through methylation markers: a two-cohort study.	Choudhary P et al.	—	2024	→
Direct targets of MEF2C are enriched for genes associated with schizophrenia and cognitive function and are involved in neuron development and mitochondrial function.	Ali D et al.	—	2024	→
Discrimination between healthy participants and people with panic disorder based on polygenic scores for psychiatric disorders and for intermediate phenotypes using machine learning.	Ohi K et al.	—	2024	→
Disentangling differing relationships between internalizing disorders and alcohol use.	Brasher MS et al.	—	2024	→
Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores.	Vilar-Ribó L et al.	—	2024	→
Distinct Longitudinal Brain White Matter Microstructure Changes and Associated Polygenic Risk of Common Psychiatric Disorders and Alzheimer's Disease in the UK Biobank.	Korbmacher M et al.	—	2024	→
Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivo.	Sportelli L et al.	—	2024	→
Epigenome-wide association study identifies neonatal DNA methylation associated with two-year attention problems in children born very preterm.	Camerota M et al.	—	2024	→
Epilepsy and psychiatric comorbidities: A bidirectional mendelian randomization study.	Chu H et al.	—	2024	→
Estimating the impact of transmitted and non-transmitted psychiatric and neurodevelopmental polygenic scores on youth emotional problems.	Shakeshaft A et al.	—	2024	→
Evaluating the link between immune characteristics and attention deficit hyperactivity disorder through a bi-directional Mendelian randomization study.	Jue H et al.	—	2024	→
Evaluating the regulatory function of non-coding autism-associated single nucleotide polymorphisms on gene expression in human brain tissue.	Pugsley K et al.	—	2024	→
Evidence for the additivity of rare and common variant burden throughout the spectrum of intellectual disability.	Urpa L et al.	—	2024	→
Examining the interaction between prenatal stress and polygenic risk for attention-deficit/hyperactivity disorder on brain growth in childhood: Findings from the DREAM BIG consortium.	López-Vicente M et al.	—	2024	→
Executive control training for adolescents with ADHD: Study protocol for a randomised controlled trial.	Dyresen A et al.	—	2024	→
Executive Function and Impulsivity Predict Distinct Genetic Variance in Internalizing Problems, Externalizing Problems, Thought Disorders, and Compulsive Disorders: A Genomic Structural Equation Modeling Study.	Gustavson DE et al.	—	2024	→
Exploring the intersection of polygenic risk scores and prenatal alcohol exposure: Unraveling the mental health equation.	Gerlikhman L et al.	—	2024	→
Familial co-aggregation and shared familiality among neurodevelopmental problems and with aggressive behavior, depression, anxiety, and substance use.	Vos M et al.	—	2024	→
Family-based genetic analysis in schizophrenia by whole-exome sequence to identify rare pathogenic variants.	Shang B et al.	—	2024	→
Fibroblasts as an in vitro model of circadian genetic and genomic studies.	Francia M et al.	—	2024	→
FORGEdb: a tool for identifying candidate functional variants and uncovering target genes and mechanisms for complex diseases.	Breeze CE et al.	—	2024	→
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care.	Baweja R et al.	—	2024	→
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD.	Parlatini V et al.	—	2024	→
Functional classes of SNPs related to psychiatric disorders and behavioral traits contrast with those related to neurological disorders.	Reimers MA et al.	—	2024	→
Gene-environment interactions in the influence of maternal education on adolescent neurodevelopment using ABCD study.	Shi R et al.	—	2024	→
Genetic and Phenotypic Features of Schizophrenia in the UK Biobank.	Legge SE et al.	—	2024	→
Genetic and phenotypic heterogeneity in early neurodevelopmental traits in the Norwegian Mother, Father and Child Cohort Study.	Hegemann L et al.	—	2024	→
Genetic architectures of cerebral ventricles and their overlap with neuropsychiatric traits.	Ge YJ et al.	—	2024	→
Genetic architectures of the human hippocampus and those involved in neuropsychiatric traits.	Ning C et al.	—	2024	→
Genetic associations and potential mediators between psychiatric disorders and irritable bowel syndrome: a Mendelian randomization study with mediation analysis.	Zhang T et al.	—	2024	→
Genetic evidence for causal effects of immune dysfunction in psychiatric disorders: where are we?	Iakunchykova O et al.	—	2024	→
Genetic influences on sibling bullying and mental health difficulties.	Toseeb U et al.	—	2024	→
Genetic liability estimated from large-scale family data improves genetic prediction, risk score profiling, and gene mapping for major depression.	Dybdahl Krebs M et al.	—	2024	→
Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis.	Aygün N et al.	—	2024	→
Genetic variants for head size share genes and pathways with cancer.	Knol MJ et al.	—	2024	→
Genetic Variations in Elements of the Oxytocinergic Pathway are Associated with Attention/Hyperactivity Problems and Anxiety Problems in Childhood.	Camerini L et al.	—	2024	→
Genome-Wide Analyses of Vocabulary Size in Infancy and Toddlerhood: Associations With Attention-Deficit/Hyperactivity Disorder, Literacy, and Cognition-Related Traits.	Verhoef E et al.	—	2024	→
Genome-Wide Association Study of Obsessive-Compulsive Symptoms including 33,943 individuals from the general population.	Strom NI et al.	—	2024	→
Genomic structural equation modeling reveals latent phenotypes in the human cortex with distinct genetic architecture.	Morey RA et al.	—	2024	→
Genotype-environment interplay in associations between maternal drinking and offspring emotional and behavioral problems.	Hannigan LJ et al.	—	2024	→
Gestational epigenetic age and ADHD symptoms in childhood: a prospective, multi-cohort study.	Salontaji K et al.	—	2024	→
G protein-coupled receptor (GPCR) pharmacogenomics.	Thompson MD et al.	—	2024	→
Illuminating Shared Genetic Associations Between Oesophageal Carcinoma and Pulmonary Carcinoma Risk.	Zhang D et al.	—	2024	→
Inactivation of ERK1/2 Signaling in Dopaminergic Neurons by Map Kinase Phosphatase MKP3 Regulates Dopamine Signaling and Motivation for Cocaine.	Bernstein DL et al.	—	2024	→
Increased Rate of Familial Mediterranean Fever in Children With ADHD: A Population-Based Case-Control Study.	Merzon E et al.	—	2024	→
Independent Prediction of Child Psychiatric Symptoms by Maternal Mental Health and Child Polygenic Risk Scores.	Chen LM et al.	—	2024	→
Infants' looking preferences for social versus non-social objects reflect genetic variation.	Portugal AM et al.	—	2024	→
Inflammatory biotype of ADHD is linked to chronic stress: a data-driven analysis of the inflammatory proteome.	Schnorr I et al.	—	2024	→
In Memoriam: Professor Joseph Biederman's Contributions to Child and Adolescent Psychiatry.	Faraone SV et al.	—	2024	→
Integrating human endogenous retroviruses into transcriptome-wide association studies highlights novel risk factors for major psychiatric conditions.	Duarte RRR et al.	—	2024	→
Integration of multi-omics summary data reveals the role of N6-methyladenosine in neuropsychiatric disorders.	Liufu C et al.	—	2024	→
Integrative multi-omics analysis of genomic, epigenomic, and metabolomics data leads to new insights for Attention-Deficit/Hyperactivity Disorder.	Hubers N et al.	—	2024	→
Intergenerational transmission of genetic risk for hyperactivity and inattention. Direct genetic transmission or genetic nurture?	Voronin I et al.	—	2024	→
Investigating grey matter volumetric trajectories through the lifespan at the individual level.	Shi R et al.	—	2024	→
Investigating the contribution of childhood maltreatment to suicide attempt: A multivariable Mendelian randomization study.	Kim MH et al.	—	2024	→
Is Attention-Deficit/Hyperactivity Disorder (ADHD) a Dimension or a Category? What Does the Relationship Between ADHD Traits and Psychosocial Quality of Life Tell Us?	Arildskov TW et al.	—	2024	→
Kdm4a is an activity downregulated barrier to generate engrams for memory separation.	Guo X et al.	—	2024	→
Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types.	Kim SS et al.	—	2024	→
Massively parallel characterization of regulatory elements in the developing human cortex.	Deng C et al.	—	2024	→
Maternal asthma and asthma exacerbation during pregnancy and attention-deficit/hyperactivity disorder in offspring: a population-based cohort study.	Ho YF et al.	—	2024	→
Maternal Fiber Intake During Pregnancy and Development of Attention-Deficit/Hyperactivity Disorder Symptoms Across Childhood: The Norwegian Mother, Father, and Child Cohort Study.	Solberg BS et al.	—	2024	→
Maternal high-fat diet-induced microbiota changes are associated with alterations in embryonic brain metabolites and adolescent behaviour.	Ratsika A et al.	—	2024	→
Maternal pre-pregnancy and prenatal penicillin, neonatal inflammation and growth factors are associated to ADHD in the offspring.	Holmgaard S et al.	—	2024	→
Mechanisms of vagus nerve stimulation for the treatment of neurodevelopmental disorders: a focus on microglia and neuroinflammation.	Gargus M et al.	—	2024	→
Mendelian randomization analyses reveal causal relationships between brain functional networks and risk of psychiatric disorders.	Mu C et al.	—	2024	→
Mendelian randomization analysis using GWAS and eQTL data to investigate the relationship between chronotype and neuropsychiatric disorders and their molecular basis.	Crinion S et al.	—	2024	→
Meta-analysis of set-based multiple phenotype association test based on GWAS summary statistics from different cohorts.	Zhu L et al.	—	2024	→
Micronutrient-Associated Single Nucleotide Polymorphism and Mental Health: A Mendelian Randomization Study.	Hui J et al.	—	2024	→
Mitochondrial related Mendelian randomization identifies causal associations between metabolic disorders and childhood neurodevelopmental disorders.	Hu C et al.	—	2024	→
MRBEE: A bias-corrected multivariable Mendelian randomization method.	Lorincz-Comi N et al.	—	2024	→
Multiomic profiling of transcription factor binding and function in human brain.	Loupe JM et al.	—	2024	→
Narcolepsy and psychiatric disorders: A bidirectional Mendelian randomization study.	Li B et al.	—	2024	→
Network-wide risk convergence in gene co-expression identifies reproducible genetic hubs of schizophrenia risk.	Borcuk C et al.	—	2024	→
Neural activation, cognitive control, and attention deficit hyperactivity disorder: Evaluating three competing etiological models.	Peisch V et al.	—	2024	→
Neurobiology of attention-deficit hyperactivity disorder: historical challenges and emerging frontiers.	Koirala S et al.	—	2024	→
Neuropsychiatric disorders, chronotype and sleep: A narrative review of GWAS findings and the application of Mendelian randomization to investigate causal relationships.	Crinion S et al.	—	2024	→
Novel genetic loci of inhibitory control in ADHD and healthy children and genetic correlations with ADHD.	Pang T et al.	—	2024	→
Novel pharmacological targets for GABAergic dysfunction in ADHD.	Ferranti AS et al.	—	2024	→
Omics Approaches to Investigate the Pathogenesis of Suicide.	Boldrini M et al.	—	2024	→
Patterns of stressful life events and polygenic scores for five mental disorders and neuroticism among adults with depression.	Crouse JJ et al.	—	2024	→
Persistent thinness and anorexia nervosa differ on a genomic level.	Hübel C et al.	—	2024	→
Phenotypic and Genetic Associations Between Preschool Fine Motor Skills and Later Neurodevelopment, Psychopathology, and Educational Achievement.	Bowler A et al.	—	2024	→
Physical activity and lung function association in a healthy community-dwelling European population.	Collaud S et al.	—	2024	→
Polygenic liabilities and treatment trajectories in early-onset depression: a Danish register-based study.	Mundy J et al.	—	2024	→
Polygenic profiles define aspects of clinical heterogeneity in attention deficit hyperactivity disorder.	LaBianca S et al.	—	2024	→
Polygenic risk for major depression, attention deficit hyperactivity disorder, neuroticism, and schizophrenia are correlated with experience of intimate partner violence.	Ratanatharathorn A et al.	—	2024	→
Polygenic Risk of Mental Disorders and Subject-Specific School Grades.	Jefsen OH et al.	—	2024	→
Polygenic score analyses on antidepressant response in late-life depression, results from the IRL-GRey study.	Elsheikh SSM et al.	—	2024	→
Polygenic Scores and Networks of Psychopathology Symptoms.	Piazza GG et al.	—	2024	→
Polygenic Scores Clarify the Relationship Between Mental Health and Gender Diversity.	Thomas TR et al.	—	2024	→
Population clustering of structural brain aging and its association with brain development.	Duan H et al.	—	2024	→
Possible roles of deep cortical neurons and oligodendrocytes in the neural basis of human sociality.	Usui N	—	2024	→
Predicting ADHD in alcohol dependence using polygenic risk scores for ADHD.	Patel KHS et al.	—	2024	→
Principal and independent genomic components of brain structure and function.	Oblong LM et al.	—	2024	→
Psychiatric polygenic risk scores: Experience, hope for utility, and concerns among child and adolescent psychiatrists.	Merner AR et al.	—	2024	→
Quantifying the relative importance of genetics and environment on the comorbidity between mental and cardiometabolic disorders using 17 million Scandinavians.	Meijsen J et al.	—	2024	→
Rare de novo damaging DNA variants are enriched in attention-deficit/hyperactivity disorder and implicate risk genes.	Olfson E et al.	—	2024	→
Recognising and responding to physical and mental health issues in neurodivergent girls and women.	Kelly C et al.	—	2024	→
Relationship between sex biases in gene expression and sex biases in autism and Alzheimer's disease.	Fass SB et al.	—	2024	→
Relative Age Effects on Attention-Deficit/Hyperactivity Disorder Symptoms and Educational Achievement: A Longitudinal UK Cohort Study.	Deng Q et al.	—	2024	→
Semaphorin 6D tunes amygdalar circuits for emotional, metabolic, and inflammatory outputs.	Nakanishi Y et al.	—	2024	→
Serum levels of glucose, thyroid stimulating hormone, and free thyroxine in boys diagnosed with attention deficit hyperactivity disorder: a cross-sectional pilot study.	Lukovac T et al.	—	2024	→
Sex affects transcriptional associations with schizophrenia across the dorsolateral prefrontal cortex, hippocampus, and caudate nucleus.	Benjamin KJM et al.	—	2024	→
Shared genetic etiology between ADHD, task-related behavioral measures and brain activation during response inhibition in a youth ADHD case-control study.	Saraçaydın G et al.	—	2024	→
Shared Genetic Links Between Sleep, Neurodevelopmental and Neuropsychiatric Conditions: A Genome-Wide and Pathway-Based Polygenic Score Analysis.	Fahey L et al.	—	2024	→
SnapHiC-G: identifying long-range enhancer-promoter interactions from single-cell Hi-C data via a global background model.	Liu W et al.	—	2024	→
Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer's disease.	Miyoshi E et al.	—	2024	→
Stratifying early-onset emotional disorders: using genetics to assess persistence in young people of European and South Asian ancestry.	Dennison CA et al.	—	2024	→
Systematic review of mitochondrial genetic variation in attention-deficit/hyperactivity disorder.	Giannoulis SV et al.	—	2024	→
Temporally distinct 3D multi-omic dynamics in the developing human brain.	Heffel MG et al.	—	2024	→
Testing maternal effects of vitamin-D and omega-3 levels on offspring neurodevelopmental traits in the Norwegian Mother, Father and Child Cohort Study.	Wootton RE et al.	—	2024	→
The Association of Redox Regulatory Drug Target Genes with Psychiatric Disorders: A Mendelian Randomization Study.	Lu Z et al.	—	2024	→
The contribution of attention-deficit/hyperactivity disorder polygenic load to metabolic and cardiovascular health outcomes: a large-scale population and sibling study.	Du Rietz E et al.	—	2024	→
The Creative Awareness Theory: A Grounded Theory Study of Inherent Self-Regulation in Attention Deficit Hyperactivity Disorder.	Champ RE et al.	—	2024	→
The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models.	MacDonald HJ et al.	—	2024	→
The effects of psychiatric disorders on the risk of chronic heart failure: a univariable and multivariable Mendelian randomization study.	Chen Y et al.	—	2024	→
The genetic architecture of substance use and its diverse correlations with mental health traits.	Wormington B et al.	—	2024	→
The genetic architecture of the human hypothalamus and its involvement in neuropsychiatric behaviours and disorders.	Chen SD et al.	—	2024	→
The genetic landscape of basal ganglia and implications for common brain disorders.	Bahrami S et al.	—	2024	→
The impact of assortative mating, participation bias and socioeconomic status on the polygenic risk of behavioural and psychiatric traits.	Cabrera-Mendoza B et al.	—	2024	→
The impact of neurocognitive and psychiatric disorders on the risk of idiopathic normal pressure hydrocephalus: A bidirectional Mendelian randomization study.	He Y et al.	—	2024	→
The interaction effects of age, APOE and common environmental risk factors on human brain structure.	Chen J et al.	—	2024	→
The known and unknown about attention deficit hyperactivity disorder (ADHD) genetics: a special emphasis on Arab population.	Mahrous NN et al.	—	2024	→
The mediating effects of mobile phone use on ADHD and educational outcomes: a two-step Mendelian randomisation study.	Lin H et al.	—	2024	→
The Microbiota-Gut-Brain Axis and Neurological Disorders: A Comprehensive Review.	Nakhal MM et al.	—	2024	→
The risk of attention deficit hyperactivity disorder symptoms in offspring of mothers with perinatal depression: A systematic review and meta-analysis.	Tusa BS et al.	—	2024	→
The structure of psychiatric comorbidity without selection and assortative mating.	Ayorech Z et al.	—	2024	→
The X-linked intellectual disability gene CUL4B is critical for memory and synaptic function.	Jiang W et al.	—	2024	→
Topologically associating domains define the impact of de novo promoter variants on autism spectrum disorder risk.	Nakamura T et al.	—	2024	→
Toward an Increased Attention on ADHD Symptoms and Traits in Young Adults: Prevalence Data From Screening Tools in a Psychiatric Outpatient Clinic.	Sanguineti C et al.	—	2024	→
Using polygenic scores in combination with symptom rating scales to identify attention-deficit/hyperactivity disorder.	Høberg A et al.	—	2024	→
Where do neurodevelopmental conditions fit in transdiagnostic psychiatric frameworks? Incorporating a new neurodevelopmental spectrum.	Michelini G et al.	—	2024	→
ZMIX: estimating ancestry proportions using GWAS association Z-scores.	Dennis T et al.	—	2024	→
150 risk variants for diverticular disease of intestine prioritize cell types and enable polygenic prediction of disease susceptibility.	Wu Y et al.	—	2023	→
A bidirectional Mendelian randomization study about the role of morning plasma cortisol in attention deficit hyperactivity disorder.	Jue H et al.	—	2023	→
adgrl3.1-deficient zebrafish show noradrenaline-mediated externalizing behaviors, and altered expression of externalizing disorder-candidate genes, suggesting functional targets for treatment.	Fontana BD et al.	—	2023	→
ADHD genetic burden associates with older epigenetic age: mediating roles of education, behavioral and sociodemographic factors among older adults.	Arpawong TE et al.	—	2023	→
ADHD: The Mammoth Task of Disentangling Genetic, Environmental, and Developmental Risk Factors.	Kittel-Schneider S	—	2023	→
ADuLT: An efficient and robust time-to-event GWAS.	Pedersen EM et al.	—	2023	→
Advances in Zebrafish as a Comprehensive Model of Mental Disorders.	Wang L et al.	—	2023	→
Alternative polyadenylation transcriptome-wide association study identifies APA-linked susceptibility genes in brain disorders.	Cui Y et al.	—	2023	→
A meta-analysis of genetic effects associated with neurodevelopmental disorders and co-occurring conditions.	Gidziela A et al.	—	2023	→
A multivariate approach to understanding the genetic overlap between externalizing phenotypes and substance use disorders.	Poore HE et al.	—	2023	→
Annotating genetic variants to target genes using H-MAGMA.	Sey NYA et al.	—	2023	→
Annual Research Review: Perspectives on progress in ADHD science - from characterization to cause.	Sonuga-Barke EJS et al.	—	2023	→
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder.	da Silva BS et al.	—	2023	→
A Potential Role for Neuroinflammation in ADHD.	Vázquez-González D et al.	—	2023	→
Appraising the role of circulating concentrations of micronutrients in attention deficit hyperactivity disorder: a Mendelian randomization study.	Sui X et al.	—	2023	→
A shared neural basis underlying psychiatric comorbidity.	Xie C et al.	—	2023	→
A single-cell multi-omic atlas spanning the adult rhesus macaque brain.	Chiou KL et al.	—	2023	→
Assessment of the Genetic Characteristics of a Generation Born during a Long-Term Socioeconomic Crisis.	Mikhailova SV et al.	—	2023	→
Associated Genetics and Connectomic Circuitry in Schizophrenia and Bipolar Disorder.	Wei Y et al.	—	2023	→
Association Between Human Blood Metabolome and the Risk of Psychiatric Disorders.	Jia Y et al.	—	2023	→
Associations between attention-deficit/hyperactivity disorder and allergic diseases: a two-sample Mendelian randomization study.	Zhang X et al.	—	2023	→
Associations Between Attention Deficit Hyperactivity Disorder Symptom Dimensions and Disordered Eating Symptoms in Adolescence: A Population-Based Twin Study.	Yilmaz Z et al.	—	2023	→
Associations between brain gene expression perturbations implicated by COVID-19 and psychiatric disorders.	Gao Y et al.	—	2023	→
Associations between health behaviours, fertility and reproductive outcomes: triangulation of evidence in the Norwegian Mother, Father and Child Cohort Study (MoBa).	Wootton RE et al.	—	2023	→
Associative gene networks reveal novel candidates important for ADHD and dyslexia comorbidity.	Hongyao HE et al.	—	2023	→
Attention Deficit-Hyperactivity Disorder (ADHD): From Abnormal Behavior to Impairment in Synaptic Plasticity.	Ugarte G et al.	—	2023	→
Attention-deficit/hyperactivity disorder symptoms and subsequent cardiometabolic disorders in adults: investigating underlying mechanisms using a longitudinal twin study.	Dobrosavljevic M et al.	—	2023	→
Attention-deficit hyperactivity disorder traits are a more important predictor of internalising problems than autistic traits.	Hargitai LD et al.	—	2023	→
Benchmarking of local genetic correlation estimation methods using summary statistics from genome-wide association studies.	Zhang C et al.	—	2023	→
Bibliometric Analysis of Research Themes and Trends of the Co-Occurrence of Autism and ADHD.	Liu A et al.	—	2023	→
Blood miRNA levels associated with ADHD traits in children across six European birth cohorts.	Dypås LB et al.	—	2023	→
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer's Disease and Neuropsychiatric Disorders.	Zhao X et al.	—	2023	→
CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and mice.	Sanchez-Roige S et al.	—	2023	→
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review.	Cortese S et al.	—	2023	→
Causal associations between female reproductive behaviors and psychiatric disorders: a lifecourse Mendelian randomization study.	Yu Y et al.	—	2023	→
Causal atlas between inflammatory bowel disease and mental disorders: a bi-directional 2-sample Mendelian randomization study.	Yang X et al.	—	2023	→
Causal effects of potential risk factors on postpartum depression: a Mendelian randomization study.	Zuo M et al.	—	2023	→
Causal relationship between psychiatric traits and temporomandibular disorders: a bidirectional two-sample Mendelian randomization study.	Xiang Y et al.	—	2023	→
Cellular Diversity in Human Subgenual Anterior Cingulate and Dorsolateral Prefrontal Cortex by Single-Nucleus RNA-Sequencing.	Kim B et al.	—	2023	→
Characterising depression trajectories in young people at high familial risk of depression.	Weavers B et al.	—	2023	→
Child Developmental MRI (CDM) project: protocol for a multi-centre, cross-sectional study on elucidating the pathophysiology of attention-deficit/hyperactivity disorder and autism spectrum disorder through a multi-dimensional approach.	Yamashita M et al.	—	2023	→
Childhood internalizing and externalizing problems and cardiovascular and diabetes mellitus risk in adolescence.	Bordelois P et al.	—	2023	→
Chronic Pain and Psychiatric Conditions.	Johnston KJA et al.	—	2023	→
Circulating Proteins Influencing Psychiatric Disease: A Mendelian Randomization Study.	Lu T et al.	—	2023	→
Co-development of attention deficit hyperactivity disorder and autistic trait trajectories from childhood to early adulthood.	Shakeshaft A et al.	—	2023	→
Cohort profile: Genetic data in the German Socio-Economic Panel Innovation Sample (SOEP-G).	Koellinger PD et al.	—	2023	→
Consensus molecular environment of schizophrenia risk genes in coexpression networks shifting across age and brain regions.	Pergola G et al.	—	2023	→
Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia.	Kim HK et al.	—	2023	→
Decoupling Sleep and Brain Size in Childhood: An Investigation of Genetic Covariation in the Adolescent Brain Cognitive Development Study.	Hernandez LM et al.	—	2023	→
Delineating early developmental pathways to ADHD: Setting an international research agenda.	Miller M et al.	—	2023	→
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses.	Als TD et al.	—	2023	→
Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank.	Fabbri C et al.	—	2023	→
Developmental milestones in early childhood and genetic liability to neurodevelopmental disorders.	Hannigan LJ et al.	—	2023	→
Differential Effects of ADHD Polygenic Risk on Cognitive Performance in Later Life.	Mansoor M et al.	—	2023	→
Direct and Indirect Genetic Effects on Aggression.	van der Laan CM et al.	—	2023	→
Disentangling the influences of parental genetics on offspring's cognition, education, and psychopathology via genetic and phenotypic pathways.	Axelrud LK et al.	—	2023	→
Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD.	Meyer GP et al.	—	2023	→
DNA methylation and general psychopathology in childhood: an epigenome-wide meta-analysis from the PACE consortium.	Rijlaarsdam J et al.	—	2023	→
DNA methylation epi-signature and biological age in attention deficit hyperactivity disorder patients.	Carvalho GFDS et al.	—	2023	→
Dopamine, Immunity, and Disease.	Channer B et al.	—	2023	→
Do Poor Diet and Lifestyle Behaviors Modify the Genetic Susceptibility to Impulsivity in the General Population?	Xie T et al.	—	2023	→
Effect of 25 hydroxyvitamin D on attention deficit and hyperactivity in school-age children with ADHD.	Yang J et al.	—	2023	→
Enrichment of self-domestication and neural crest function loci in the heritability of neurodevelopmental disorders.	Koller D et al.	—	2023	→
Environmental carcinogens disproportionally mutate genes implicated in neurodevelopmental disorders.	Baker BH et al.	—	2023	→
Epigenetics applied to child and adolescent mental health: Progress, challenges and opportunities.	Cecil CAM et al.	—	2023	→
Epigenome-wide DNA methylation in externalizing behaviours: A review and combined analysis.	Meijer M et al.	—	2023	→
Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges.	Fan HC et al.	—	2023	→
eQTL colocalization analysis highlights novel susceptibility genes in Autism Spectrum Disorders (ASD).	Dominguez-Alonso S et al.	—	2023	→
Evidence from "big data" for the default-mode hypothesis of ADHD: a mega-analysis of multiple large samples.	Norman LJ et al.	—	2023	→
Examining the relationship between birth weight and attention-deficit hyperactivity disorder diagnosis.	Ni M et al.	—	2023	→
Examining the relationship between genetic risk for depression and youth episodic stress exposure.	Harrison TJ et al.	—	2023	→
Exploratory factor analysis of shared and specific genetic associations in depression and anxiety.	Li C et al.	—	2023	→
From attention-deficit hyperactivity disorder to sporadic Alzheimer's disease-Wnt/mTOR pathways hypothesis.	Grünblatt E et al.	—	2023	→
Functional and molecular characterization of suicidality factors using phenotypic and genome-wide data.	Quintero Reis A et al.	—	2023	→
Gene-environment correlations and genetic confounding underlying the association between media use and mental health.	Ayorech Z et al.	—	2023	→
General <i>v</i>. specific vulnerabilities: polygenic risk scores and higher-order psychopathology dimensions in the Adolescent Brain Cognitive Development (ABCD) Study.	Waszczuk MA et al.	—	2023	→
Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.	Diouf D et al.	—	2023	→
Genetic and Geographical Associations With Six Dimensions of Psychotic Experiences in Adolesence.	Maxwell J et al.	—	2023	→
Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes.	Ribasés M et al.	—	2023	→
Genetic architecture of the white matter connectome of the human brain.	Sha Z et al.	—	2023	→
Genetic background to attention deficit and hyperactivity disorder and attention deficit and hyperactivity disorder symptoms at the age of 5 years: the role of sleep duration.	Morales-Muñoz I et al.	—	2023	→
Genetic correlates of vitamin D-binding protein and 25-hydroxyvitamin D in neonatal dried blood spots.	Albiñana C et al.	—	2023	→
Genetic liability to mental disorders in relation to the risk of hypertension.	Huangfu N et al.	—	2023	→
Genetic nurture versus genetic transmission of risk for ADHD traits in the Norwegian Mother, Father and Child Cohort Study.	Pingault JB et al.	—	2023	→
Genetic patterning for child psychopathology is distinct from that for adults and implicates fetal cerebellar development.	Hughes DE et al.	—	2023	→
Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus.	Wang J et al.	—	2023	→
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adults.	Leffa DT et al.	—	2023	→
Genetic support of a causal relationship between cannabis use and educational attainment: a two-sample Mendelian randomization study of European ancestry.	Chen D et al.	—	2023	→
Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains.	Demontis D et al.	—	2023	→
Genome-wide association study of cerebellar white matter microstructure and genetic overlap with common brain disorders.	Wu BS et al.	—	2023	→
Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders.	Liu J et al.	—	2023	→
Genomic patterns linked to gray matter alterations underlying working memory deficits in adults and adolescents with attention-deficit/hyperactivity disorder.	Duan K et al.	—	2023	→
Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study.	Yde Ohki CM et al.	—	2023	→
Growth Trajectories in Stimulant-Treated Children Ages 6 to 12: An Electronic Medical Record Analysis.	Biederman J et al.	—	2023	→
Guidelines for Evaluating the Comparability of Down-Sampled GWAS Summary Statistics.	Williams CM et al.	—	2023	→
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.	Docherty AR et al.	—	2023	→
Harnessing Deep Learning for Omics in an Era of COVID-19.	Jahanyar B et al.	—	2023	→
How can we improve the management of individuals with attention deficit hyperactivity disorders and co-occurring cardiometabolic disease?	Larsson H	—	2023	→
Human microglia maturation is underpinned by specific gene regulatory networks.	Han CZ et al.	—	2023	→
Hunting for Genes Underlying Emotionality in the Laboratory Rat: Maps, Tools and Traps.	Ramos A et al.	—	2023	→
Identification of brain cell types underlying genetic association with word reading and correlated traits.	Price KM et al.	—	2023	→
Identification of novel genomic risk loci shared between common epilepsies and psychiatric disorders.	Karadag N et al.	—	2023	→
Identifying potential risk genes and pathways for neuropsychiatric and substance use disorders using intermediate molecular mediator information.	Gedik H et al.	—	2023	→
Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk.	Powell SK et al.	—	2023	→
Inferring cell-type-specific causal gene regulatory networks during human neurogenesis.	Aygün N et al.	—	2023	→
Inflammation, Dopaminergic Brain and Bilirubin.	Jayanti S et al.	—	2023	→
Integrative Multi-omics Analysis of Childhood Aggressive Behavior.	Hagenbeek FA et al.	—	2023	→
Interaction of genetic liability for attention deficit hyperactivity disorder (ADHD) and perinatal inflammation contributes to ADHD symptoms in children.	Takahashi N et al.	—	2023	→
Investigating Direct and Indirect Genetic Effects in Attention-Deficit/Hyperactivity Disorder Using Parent-Offspring Trios.	Martin J et al.	—	2023	→
Investigating the shared genetic architecture and causal relationship between pain and neuropsychiatric disorders.	Chen M et al.	—	2023	→
Investigation of the forkhead box protein P2 gene by the next-generation sequence analysis method in children diagnosed with specific learning disorder.	Yazıcı M et al.	—	2023	→
<i>RBFOX1</i> and Working Memory: From Genome to Transcriptome Revealed Posttranscriptional Mechanism Separate From Attention-Deficit/Hyperactivity Disorder.	Zhong Y et al.	—	2023	→
Is adjustment disorder genetically correlated with depression, anxiety, or risk-tolerant personality trait?	Ohi K et al.	—	2023	→
Isoform-level transcriptome-wide association uncovers genetic risk mechanisms for neuropsychiatric disorders in the human brain.	Bhattacharya A et al.	—	2023	→
Is there evidence of a causal link between childhood maltreatment and attention deficit/hyperactivity disorder? A systematic review of prospective longitudinal studies using the Bradford-Hill criteria.	Bali P et al.	—	2023	→
Joint polygenic and environmental risks for childhood attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom dimensions.	Mooney MA et al.	—	2023	→
Leveraging related health phenotypes for polygenic prediction of impulsive choice, impulsive action, and impulsive personality traits in 1534 European ancestry community adults.	Deng WQ et al.	—	2023	→
Lineage specific 3D genome structure in the adult human brain and neurodevelopmental changes in the chromatin interactome.	Rahman S et al.	—	2023	→
Machine Learning and MRI-based Diagnostic Models for ADHD: Are We There Yet?	Zhang-James Y et al.	—	2023	→
Machine learning dissection of human accelerated regions in primate neurodevelopment.	Whalen S et al.	—	2023	→
Machine learning in attention-deficit/hyperactivity disorder: new approaches toward understanding the neural mechanisms.	Cao M et al.	—	2023	→
Mapping microRNA expression quantitative trait loci in the prenatal human brain implicates miR-1908-5p expression in bipolar disorder and other brain-related traits.	Toste CC et al.	—	2023	→
Mapping Normative Trajectories of Cognitive Function and Its Relation to Psychopathology Symptoms and Genetic Risk in Youth.	Kjelkenes R et al.	—	2023	→
Mapping the cortico-striatal transcriptome in attention deficit hyperactivity disorder.	Sudre G et al.	—	2023	→
Maternal depression and the polygenic p factor: A family perspective on direct and indirect effects.	Ayorech Z et al.	—	2023	→
Maternal psychosocial stress during pregnancy and offspring neurobehavioral outcomes during early childhood in the Healthy Start Study.	Dhaliwal SK et al.	—	2023	→
Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns.	Oliva V et al.	—	2023	→
Mendelian randomization analyses identify bidirectional causal relationships of obesity with psychiatric disorders.	Chen W et al.	—	2023	→
Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes.	Soler Artigas M et al.	—	2023	→
Mendelian randomization investigation highlights different roles of selenium status in mental disorders.	Guo X et al.	—	2023	→
Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.	Li X et al.	—	2023	→
Modeling tissue co-regulation estimates tissue-specific contributions to disease.	Amariuta T et al.	—	2023	→
Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis.	Kuś J et al.	—	2023	→
MR-DoC2: Bidirectional Causal Modeling with Instrumental Variables and Data from Relatives.	Castro-de-Araujo LFS et al.	—	2023	→
Multi-omics approach reveals dysregulated genes during hESCs neuronal differentiation exposure to paracetamol.	Spildrejorde M et al.	—	2023	→
Multi-PGS enhances polygenic prediction by combining 937 polygenic scores.	Albiñana C et al.	—	2023	→
Multiple genes in a single GWAS risk locus synergistically mediate aberrant synaptic development and function in human neurons.	Zhang S et al.	—	2023	→
Multivariate genomic architecture of cortical thickness and surface area at multiple levels of analysis.	Grotzinger AD et al.	—	2023	→
Necessity of an Integrative Animal Model for a Comprehensive Study of Attention-Deficit/Hyperactivity Disorder.	Lee WS et al.	—	2023	→
Neurogenetic mechanisms of risk for ADHD: Examining associations of polygenic scores and brain volumes in a population cohort.	He Q et al.	—	2023	→
New Research Perspectives on the Interplay Between Genes and Environment on Executive Function Development.	Miguel PM et al.	—	2023	→
Novel Functional Genomics Approaches Bridging Neuroscience and Psychiatry.	Restrepo-Lozano JM et al.	—	2023	→
Ocular and neural genes jointly regulate the visuospatial working memory in ADHD children.	Zhao Y et al.	—	2023	→
Paediatric obesity and metabolic syndrome associations with cognition and the brain in youth: Current evidence and future directions.	Sadler JR et al.	—	2023	→
Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management.	O'Connor L et al.	—	2023	→
Pervasive Downward Bias in Estimates of Liability-Scale Heritability in Genome-wide Association Study Meta-analysis: A Simple Solution.	Grotzinger AD et al.	—	2023	→
Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors.	Sanchez Ruiz JA et al.	—	2023	→
Polygenic contributions to performance on the Balloon Analogue Risk Task.	Nurmi EL et al.	—	2023	→
Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome.	Jain P et al.	—	2023	→
Polygenic risk score for attention-deficit/hyperactivity disorder and brain functional networks segregation in a community-based sample.	Sato JR et al.	—	2023	→
Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents.	Zwicker A et al.	—	2023	→
Polygenic scores for psychiatric disorders in a diverse postmortem brain tissue cohort.	Duncan L et al.	—	2023	→
Postpartum and non-postpartum depression: a population-based matched case-control study comparing polygenic risk scores for severe mental disorders.	Munk-Olsen T et al.	—	2023	→
Practitioner Review: Attention-deficit hyperactivity disorder and autism spectrum disorder - the importance of depression.	Thapar A et al.	—	2023	→
Preliminary Evidence for Genetic Nurture in Depression and Neuroticism Through Polygenic Scores.	Tubbs JD et al.	—	2023	→
Prioritization of potential causative genes for schizophrenia in placenta.	Ursini G et al.	—	2023	→
Prioritizing genes associated with brain disorders by leveraging enhancer-promoter interactions in diverse neural cells and tissues.	Zhao X et al.	—	2023	→
Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.	Pintacuda G et al.	—	2023	→
Psychiatric disorders and cardiovascular diseases: A mendelian randomization study.	Sui X et al.	—	2023	→
Psychiatric disorders and Type 2 diabetes mellitus: A bidirectional Mendelian randomization.	Tao H et al.	—	2023	→
Psychostimulants for Children: Are We Over or Under Dosing?	Blum K et al.	—	2023	→
Rare copy number variants in males and females with childhood attention-deficit/hyperactivity disorder.	Jung B et al.	—	2023	→
Refining patterns of MEF2C effects in white matter microstructure and psychiatric features.	de Araujo Tavares ME et al.	—	2023	→
Relationship between sex biases in gene expression and sex biases in autism and Alzheimer’s disease	Fass SB et al.	—	2023	—
Replication of a predictive model for youth ADHD in an independent sample from a developing country.	Lorenzi CH et al.	—	2023	→
Robustness of quantifying mediating effects of genetically regulated expression on complex traits with mediated expression score regression.	Lin C et al.	—	2023	→
Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders: A Genome-Wide Pleiotropic Analysis.	Gong W et al.	—	2023	→
Roles of obesity in mediating the causal effect of attention-deficit/hyperactivity disorder on diabetes.	Liu N et al.	—	2023	→
School performance and genetic propensities for educational attainment and depression in the etiology of self-harm: a Danish population-based study.	Sørensen HJ et al.	—	2023	→
Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan.	Vilar-Ribó L et al.	—	2023	→
Shared genetic architecture between mental health and the brain functional connectome in the UK Biobank.	Roelfs D et al.	—	2023	→
Shared Genetic Risk in the Association of Screen Time With Psychiatric Problems in Children.	Zhang Y et al.	—	2023	→
Shared genetics and bidirectional causal relationships between type 2 diabetes and attention-deficit/hyperactivity disorder.	Baranova A et al.	—	2023	→
Shared genetics of psychiatric disorders and type 2 diabetes:a large-scale genome-wide cross-trait analysis.	Ding H et al.	—	2023	→
SLCO5A1 and synaptic assembly genes contribute to impulsivity in juvenile myoclonic epilepsy.	Roshandel D et al.	—	2023	→
Sleep disturbances in ADHD: investigating the contribution of polygenic liability for ADHD and sleep-related phenotypes.	Lewis KJS et al.	—	2023	→
Sleep Health at the Genomic Level: Six Distinct Factors and Their Relationships With Psychopathology.	Morrison CL et al.	—	2023	→
Social isolation-induced transcriptomic changes in mouse hippocampus impact the synapse and show convergence with human genetic risk for neurodevelopmental phenotypes.	Laighneach A et al.	—	2023	→
Structure-informed clustering for population stratification in association studies.	Bose A et al.	—	2023	→
Swedish multimodal cohort of patients with anxiety or depression treated with internet-delivered psychotherapy (MULTI-PSYCH).	Boberg J et al.	—	2023	→
Testing the causal relationships of physical activity and sedentary behaviour with mental health and substance use disorders: a Mendelian randomisation study.	Iob E et al.	—	2023	→
The association between polygenic risk scores for mental disorders and social cognition: A scoping review.	Fusar-Poli L et al.	—	2023	→
The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study.	Garcia-Argibay M et al.	—	2023	→
The Big (Genetic) Sort? A Research Note on Migration Patterns and Their Genetic Imprint in the United Kingdom.	Furuya S et al.	—	2023	→
The combination of autism and exceptional cognitive ability is associated with suicidal ideation.	Casten LG et al.	—	2023	→
The contribution of copy number variants to psychiatric symptoms and cognitive ability.	Mollon J et al.	—	2023	→
The correlates of neonatal complement component 3 and 4 protein concentrations with a focus on psychiatric and autoimmune disorders.	Borbye-Lorenzen N et al.	—	2023	→
The Development of Mental Health Difficulties in Young People With and Without Developmental Language Disorder: A Gene-Environment Interplay Study Using Polygenic Scores.	Toseeb U et al.	—	2023	→
The early life course-related traits with three psychiatric disorders: A two-sample Mendelian randomization study.	He R et al.	—	2023	→
The efficacy of physical exercise interventions on mental health, cognitive function, and ADHD symptoms in children and adolescents with ADHD: an umbrella review.	Dastamooz S et al.	—	2023	→
The genetic architecture of human amygdala volumes and their overlap with common brain disorders.	Ou YN et al.	—	2023	→
The genetic architecture of the corpus callosum and its genetic overlap with common neuropsychiatric diseases.	Chen SJ et al.	—	2023	→
The interactions between host genome and gut microbiome increase the risk of psychiatric disorders: Mendelian randomization and biological annotation.	Xiao L et al.	—	2023	→
The Relationship of Attention-Deficit/Hyperactivity Disorder With Posttraumatic Stress Disorder: A Two-Sample Mendelian Randomization and Population-Based Sibling Comparison Study.	Wendt FR et al.	—	2023	→
The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders.	Rasmi Y et al.	—	2023	→
The shared genetic landscape of blood cell traits and risk of neurological and psychiatric disorders.	Yang Y et al.	—	2023	→
The shared genetic risk factors between Tourette syndrome and obsessive-compulsive disorder.	Khoodoruth MAS et al.	—	2023	→
The synergistic effect of genetic and environmental factors in the development of attention-deficit/hyperactivity disorder symptoms in children and adolescents.	Leffa DT et al.	—	2023	→
The translational genetics of ADHD and related phenotypes in model organisms.	Cabana-Domínguez J et al.	—	2023	→
Trans-ancestry meta-analysis of genome wide association studies of inhibitory control.	Arnatkeviciute A et al.	—	2023	→
Transcriptional signatures of heroin intake and relapse throughout the brain reward circuitry in male mice.	Browne CJ et al.	—	2023	→
Transcriptome-wide association study by different approaches reveals candidate causal genes for cannabis use disorder.	Gao J et al.	—	2023	→
Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing.	Grotzinger AD et al.	—	2023	→
Transcriptomic risk scores for attention deficit/hyperactivity disorder.	Cabana-Domínguez J et al.	—	2023	→
Transdiagnostic biomarkers of mental illness across the lifespan: A systematic review examining the genetic and neural correlates of latent transdiagnostic dimensions of psychopathology in the general population.	Hoy N et al.	—	2023	→
Transition of allele-specific DNA hydroxymethylation at regulatory loci is associated with phenotypic variation in monozygotic twins discordant for psychiatric disorders.	Ye J et al.	—	2023	→
TTLL11 gene is associated with sustained attention performance and brain networks: A genome-wide association study of a healthy Chinese sample.	Liu H et al.	—	2023	→
Two-sample Mendelian randomization analysis investigates causal associations between gut microbiota and attention deficit hyperactivity disorder.	Wang L et al.	—	2023	→
Understanding mental health through computers: An introduction to computational psychiatry.	Castro Martínez JC et al.	—	2023	→
Understanding the causal relationships of attention-deficit/hyperactivity disorder with mental disorders and suicide attempt: a network Mendelian randomisation study.	Meisinger C et al.	—	2023	→
Understanding the relationship between loneliness, substance use traits and psychiatric disorders: A genetically informed approach.	Martin E et al.	—	2023	→
Unraveling shared susceptibility loci and Mendelian genetic associations linking educational attainment with multiple neuropsychiatric disorders.	Chen D et al.	—	2023	→
Update on genetics of attention deficit/hyperactivity disorder: current status 2023.	Kranz TM et al.	—	2023	→
Use of big data and machine learning algorithms to extract possible treatment targets in neurodevelopmental disorders.	Malik MA et al.	—	2023	→
Using allele scores to identify confounding by reverse causation: studies of alcohol consumption as an exemplar.	Sallis HM et al.	—	2023	→
Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia.	Hsu YH et al.	—	2023	→
White matter alterations in Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review of 129 diffusion imaging studies with meta-analysis.	Parlatini V et al.	—	2023	→
Youth Polygenic Scores, Youth ADHD Symptoms, and Parenting Dimensions: An Evocative Gene-Environment Correlation Study.	de la Paz L et al.	—	2023	→
Youth Team Sports Participation Associates With Reduced Dimensional Psychopathology Through Interaction With Biological Risk Factors.	Kunitoki K et al.	—	2023	→
Accounting for age of onset and family history improves power in genome-wide association studies.	Pedersen EM et al.	—	2022	→
A cognitive neurogenetic approach to uncovering the structure of executive functions.	Feng J et al.	—	2022	→
ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the incretin polypeptide GIP.	Vidal OM et al.	—	2022	→
ADHD and its neurocognitive substrates: A two sample Mendelian randomization study.	Ahn K et al.	—	2022	→
ADHD-associated PARK2 copy number variants: A pilot study on gene expression and effects of supplementary deprivation in patient-derived cell lines.	Radtke F et al.	—	2022	→
ADHD co-morbidities: A review of implication of gene × environment effects with dopamine-related genes.	Kanarik M et al.	—	2022	→
ADHD in Adults: A Systematic Review and Meta-Analysis of Prevalence Studies in Outpatient Psychiatric Clinics.	Adamis D et al.	—	2022	→
A Gene-Environment Interaction Study of Polygenic Scores and Maltreatment on Childhood ADHD.	He Q et al.	—	2022	→
A genome-wide association study of total child psychiatric problems scores.	Neumann A et al.	—	2022	→
A mechanistic model of ADHD as resulting from dopamine phasic/tonic imbalance during reinforcement learning.	Véronneau-Veilleux F et al.	—	2022	→
An atlas of genetic correlations between gestational age and common psychiatric disorders.	Yao Y et al.	—	2022	→
An atlas of transcriptionally defined cell populations in the rat ventral tegmental area.	Phillips RA et al.	—	2022	→
An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities.	Slaby I et al.	—	2022	→
A novel cis-regulatory variant modulating TIE1 expression associated with attention deficit hyperactivity disorder in Han Chinese children.	Chen X et al.	—	2022	→
A phenome-wide association study of polygenic scores for attention deficit hyperactivity disorder across two genetic ancestries in electronic health record data.	Niarchou M et al.	—	2022	→
Association between Exposure to Particulate Matter Air Pollution during Early Childhood and Risk of Attention-Deficit/Hyperactivity Disorder in Taiwan.	Fan HC et al.	—	2022	→
Association between plasma proteome and childhood neurodevelopmental disorders: A two-sample Mendelian randomization analysis.	Yang J et al.	—	2022	→
Association of autism diagnosis and polygenic scores with eating disorder severity.	Zhang R et al.	—	2022	→
Association of maternal polygenic risk scores for mental illness with perinatal risk factors for offspring mental illness.	Ratanatharathorn A et al.	—	2022	→
Association of polygenic risk scores and hair cortisol with mental health trajectories during COVID lockdown.	Ahrens KF et al.	—	2022	→
Association of sweetened carbonated beverage consumption during pregnancy and ADHD symptoms in the offspring: a study from the Norwegian Mother, Father and Child Cohort Study (MoBa).	Kvalvik LG et al.	—	2022	→
Associations between Allergic and Autoimmune Diseases with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder within Families: A Population-Based Cohort Study.	Li DJ et al.	—	2022	→
Associations between brain imaging and polygenic scores of mental health and educational attainment in children aged 9-11.	Fernandez-Cabello S et al.	—	2022	→
Associations between mental and physical conditions in children and adolescents: An umbrella review.	Arrondo G et al.	—	2022	→
Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia: The Norwegian Mother, Father and Child Cohort Study (MoBa).	Havdahl A et al.	—	2022	→
A Systematic Screening of ADHD-Susceptible Variants From 25 Chinese Parents-Offspring Trios.	Li Q et al.	—	2022	→
Attention-deficit/hyperactivity disorder and Alzheimer's disease and any dementia: A multi-generation cohort study in Sweden.	Zhang L et al.	—	2022	→
Attention-Deficit/Hyperactivity Disorder, Insomnia, and Sleepiness Symptoms among a Community Adult Sample: The Mediating Effect of Executive Behavioral Regulation and Metacognition Abilities.	Madiouni C et al.	—	2022	→
Attention-Deficit/Hyperactivity Disorder: Restricted Phenotypes Prevalence, Comorbidity, and Polygenic Risk Sensitivity in the ABCD Baseline Cohort.	Cordova MM et al.	—	2022	→
Base-edited cynomolgus monkeys mimic core symptoms of STXBP1 encephalopathy.	Lu Z et al.	—	2022	→
Behavioral impulsivity is associated with pupillary alterations and hyperactivity in CDKL5 mutant mice.	Viglione A et al.	—	2022	→
Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study.	Hughes AM et al.	—	2022	→
Broad transcriptomic dysregulation occurs across the cerebral cortex in ASD.	Gandal MJ et al.	—	2022	→
Caffeine-related genes influence anxiety disorders in children and adults with ADHD.	Fraporti TT et al.	—	2022	→
Charting the Landscape of Genetic Overlap Between Mental Disorders and Related Traits Beyond Genetic Correlation.	Hindley G et al.	—	2022	→
Chromatin modifier developmental pluripotency associated factor 4 (DPPA4) is a candidate gene for alcohol-induced developmental disorders.	Auvinen P et al.	—	2022	→
chromMAGMA: regulatory element-centric interrogation of risk variants.	Nameki R et al.	—	2022	→
Classifying major mental disorders genetically.	Cao H et al.	—	2022	→
Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder.	Nunez NA et al.	—	2022	→
Clinical autism subscales have common genetic liabilities that are heritable, pleiotropic, and generalizable to the general population.	Thomas TR et al.	—	2022	→
Cohort Profile Update: The TRacking Adolescents' Individual Lives Survey-The Next Generation (TRAILS NEXT).	Hartman CA et al.	—	2022	→
Collective genomic segments with differential pleiotropic patterns between cognitive dimensions and psychopathology.	Lam M et al.	—	2022	→
Complementary and Alternative Medicine Use by ADHD Patients: A Systematic Review.	Wu J et al.	—	2022	→
Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models.	Dejanovic B et al.	—	2022	→
Composition of the Gut Microbiota in Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis.	Wang N et al.	—	2022	→
Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit/Hyperactivity Disorder (ADHD).	Cabana-Domínguez J et al.	—	2022	→
Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders.	Cabana-Domínguez J et al.	—	2022	→
Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose.	Corradin O et al.	—	2022	→
Correlation research of susceptibility single nucleotide polymorphisms and the severity of clinical symptoms in attention deficit hyperactivity disorder.	Xu Y et al.	—	2022	→
Corticolimbic DCC gene co-expression networks as predictors of impulsivity in children.	Restrepo-Lozano JM et al.	—	2022	→
Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction.	Kember RL et al.	—	2022	→
Cross-Disorder Analysis of Shared Genetic Components Between Cortical Structures and Major Psychiatric Disorders.	Li Z et al.	—	2022	→
Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease.	Uellendahl-Werth F et al.	—	2022	→
Differences in the genetic architecture of common and rare variants in childhood, persistent and late-diagnosed attention-deficit hyperactivity disorder.	Rajagopal VM et al.	—	2022	→
Disentangling Genetic Risks for Metabolic Syndrome.	van Walree ES et al.	—	2022	→
Dissecting the molecular basis of human interneuron migration in forebrain assembloids from Timothy syndrome.	Birey F et al.	—	2022	→
Dissociation in Neural Correlates of Hyperactive/Impulsive vs. Inattentive Symptoms in Attention-Deficit/Hyperactivity Disorder.	Luo Y et al.	—	2022	→
Distributed genetic architecture across the hippocampal formation implies common neuropathology across brain disorders.	Bahrami S et al.	—	2022	→
DNA methylation analysis using bisulphite-based amplicon sequencing of individuals exposed to maternal tobacco use during pregnancy, and offspring conduct problems in childhood and adolescence.	Noble AJ et al.	—	2022	→
Driving risks of young drivers with symptoms of attention deficit hyperactivity disorder: association with the dopamine transporter gene VNTR polymorphism.	Tokko T et al.	—	2022	→
Dynamic proteomic and phosphoproteomic atlas of corticostriatal axons in neurodevelopment.	Dumrongprechachan V et al.	—	2022	→
Early-Life Injuries and the Development of Attention-Deficit/Hyperactivity Disorder.	Wimberley T et al.	—	2022	→
Early manifestations of genetic liability for ADHD, autism and schizophrenia at ages 18 and 24 months.	Riglin L et al.	—	2022	→
Early manifestations of genetic risk for neurodevelopmental disorders.	Askeland RB et al.	—	2022	→
Eating disorder symptoms and their associations with anthropometric and psychiatric polygenic scores.	Abdulkadir M et al.	—	2022	→
Enhancing Discovery of Genetic Variants for Posttraumatic Stress Disorder Through Integration of Quantitative Phenotypes and Trauma Exposure Information.	Maihofer AX et al.	—	2022	→
Enhancing neuroimaging genetics through meta-analysis for Tourette syndrome (ENIGMA-TS): A worldwide platform for collaboration.	Paschou P et al.	—	2022	→
Enrichment analyses identify shared associations for 25 quantitative traits in over 600,000 individuals from seven diverse ancestries.	Smith SP et al.	—	2022	→
Epigenetics and ADHD.	Silk T et al.	—	2022	→
Epigenetics and ADHD: Reflections on Current Knowledge, Research Priorities and Translational Potential.	Cecil CAM et al.	—	2022	→
Examining the source of increased bipolar disorder and major depressive disorder common risk variation burden in multiplex schizophrenia families.	Ahangari M et al.	—	2022	→
Exploration of Sleep Parameters, Daytime Hyperactivity/Inattention, and Attention-Deficit/Hyperactivity Disorder Polygenic Risk Scores of Children in a Birth Cohort in Japan.	Takahashi N et al.	—	2022	→
Exploring the causal effects of genetic liability to ADHD and Autism on Alzheimer's disease.	Pagoni P et al.	—	2022	→
Exploring the genetic overlap between twelve psychiatric disorders.	Romero C et al.	—	2022	→
Extended gene set analysis of human neuro-psychiatric traits shows enrichment in brain-expressed human accelerated regions across development.	Cheung JP et al.	—	2022	→
Familial co-aggregation of attention-deficit/hyperactivity disorder and autoimmune diseases: a cohort study based on Swedish population-wide registers.	Hegvik TA et al.	—	2022	→
Five Major Psychiatric Disorders and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.	Wei T et al.	—	2022	→
FOXP2 down expression is associated with executive dysfunctions and electrophysiological abnormalities of brain in Autism spectrum disorder; a neuroimaging genetic study.	Haghighatfard A et al.	—	2022	→
Functional variant rs2270363 on 16p13.3 confers schizophrenia risk by regulating NMRAL1.	Wang J et al.	—	2022	→
Gene-environment interaction using polygenic scores: Do polygenic scores for psychopathology moderate predictions from environmental risk to behavior problems?	Plomin R et al.	—	2022	→
Gene expression associated with human brain activations in facial expression recognition.	Wang Z et al.	—	2022	→
Genes regulating levels of ω-3 long-chain polyunsaturated fatty acids are associated with alcohol use disorder and consumption, and broader externalizing behavior in humans.	Aliev F et al.	—	2022	→
Genetic and psychosocial influence on the association between early childhood infections and later psychiatric disorders.	Debost JPG et al.	—	2022	→
Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis.	Grotzinger AD et al.	—	2022	→
Genetic common variants associated with cerebellar volume and their overlap with mental disorders: a study on 33,265 individuals from the UK-Biobank.	Chambers T et al.	—	2022	→
Genetic correlates of phenotypic heterogeneity in autism.	Warrier V et al.	—	2022	→
Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders.	Reay WR et al.	—	2022	→
Genetic heterogeneity and subtypes of major depression.	Nguyen TD et al.	—	2022	→
Genetic identification of tissues and cell types underlying attention-deficit/hyperactivity disorder.	Wei WQ et al.	—	2022	→
Genetic origins of schizophrenia find common ground.	Iyegbe CO et al.	—	2022	→
Genetic Relationships between Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, and Intelligence.	Rao S et al.	—	2022	→
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder.	Reay WR et al.	—	2022	→
Genetics in psychiatry: Methods, clinical applications and future perspectives.	Fabbri C	—	2022	→
Genetics in the ADHD Clinic: How Can Genetic Testing Support the Current Clinical Practice?	Balogh L et al.	—	2022	→
Genetics of age-at-onset in major depression.	Harder A et al.	—	2022	→
Genetics of Attention-Deficit Hyperactivity Disorder.	Langley K et al.	—	2022	→
Genetic variants associated with longitudinal changes in brain structure across the lifespan.	Brouwer RM et al.	—	2022	→
Genetic variants associated with psychiatric disorders are enriched at epigenetically active sites in lymphoid cells.	Lynall ME et al.	—	2022	→
Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder.	Haavik J	—	2022	→
Genome-wide analyses of individual differences in quantitatively assessed reading- and language-related skills in up to 34,000 people.	Eising E et al.	—	2022	→
Genome-Wide Association Study and Genetic Correlation Scan Provide Insights into Its Genetic Architecture of Sleep Health Score in the UK Biobank Cohort.	Yao Y et al.	—	2022	→
Genome-wide association study of cerebellar volume provides insights into heritable mechanisms underlying brain development and mental health.	Tissink E et al.	—	2022	→
Genome-wide association study of pain sensitivity assessed by questionnaire and the cold pressor test.	Fontanillas P et al.	—	2022	→
Genome-wide tandem repeat expansions contribute to schizophrenia risk.	Mojarad BA et al.	—	2022	→
Global DNA methylation changes in adults with attention deficit-hyperactivity disorder and its comorbidity with bipolar disorder: links with polygenic scores.	Müller D et al.	—	2022	→
Gut metagenomic characteristics of ADHD reveal low <i>Bacteroides ovatus</i>-associated host cognitive impairment.	Li Y et al.	—	2022	→
Heritability and Clinical Characteristics of Neuropsychological Profiles in Youth With and Without Elevated ADHD Symptoms.	Arnett AB et al.	—	2022	→
Higher Risk of Mortality for Individuals Diagnosed With Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder Demands a Public Health Prevention Strategy.	Barkley RA et al.	—	2022	→
High polygenic predisposition for ADHD and a greater risk of all-cause mortality: a large population-based longitudinal study.	Ajnakina O et al.	—	2022	→
How genetic analysis may contribute to the understanding of avoidant/restrictive food intake disorder (ARFID).	Kennedy HL et al.	—	2022	→
How interactions between ADHD and schools affect educational achievement: a family-based genetically sensitive study.	Cheesman R et al.	—	2022	→
Identification of genetic variants influencing methylation in brain with pleiotropic effects on psychiatric disorders.	Pineda-Cirera L et al.	—	2022	→
Identification of shared and differentiating genetic architecture for autism spectrum disorder, attention-deficit hyperactivity disorder and case subgroups.	Mattheisen M et al.	—	2022	→
Identifying pleiotropic genes for complex phenotypes with summary statistics from a perspective of composite null hypothesis testing.	Wang T et al.	—	2022	→
Identifying pleiotropic genes for major psychiatric disorders with GWAS summary statistics using multivariate adaptive association tests.	Wang Y et al.	—	2022	→
Identifying the Common Genetic Basis of Antidepressant Response.	Pain O et al.	—	2022	→
Immune marker levels in severe mental disorders: associations with polygenic risk scores of related mental phenotypes and psoriasis.	Werner MCF et al.	—	2022	→
Individual differences in sensitivity to positive home environment among children "at risk" for attention-deficit/hyperactivity disorder: A review.	Einziger T et al.	—	2022	→
Infection Polygenic Factors Account for a Small Proportion of the Relationship Between Infections and Mental Disorders.	Shorter JR et al.	—	2022	→
Influences on the Genetic Relationship Between Cannabis Use and Schizophrenia: The Role of the Externalizing Spectrum.	Wormington B et al.	—	2022	→
Innovative computational approaches shed light on genetic mechanisms underlying cognitive impairment among children born extremely preterm.	Liu W et al.	—	2022	→
Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders.	Fanelli G et al.	—	2022	→
Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability.	Feleke R et al.	—	2022	→
Interindividual Differences in Cortical Thickness and Their Genomic Underpinnings in Autism Spectrum Disorder.	Ecker C et al.	—	2022	→
Investigating genetic overlaps of the genetic factor differentiating schizophrenia from bipolar disorder with cognitive function and hippocampal volume.	Ohi K et al.	—	2022	→
Investigating the causal risk factors for self-harm by integrating Mendelian randomisation within twin modelling.	Lim KX et al.	—	2022	→
Is genetic risk of ADHD mediated via dopaminergic mechanism? A study of functional connectivity in ADHD and pharmacologically challenged healthy volunteers with a genetic risk profile.	Grimm O et al.	—	2022	→
Keeping the balance: Trade-offs between human brain evolution, autism, and schizophrenia.	Duński E et al.	—	2022	→
Latent subtypes of manic and/or irritable episode symptoms in two population-based cohorts - ERRATUM.	Arathimos R et al.	—	2022	→
"Late-onset" ADHD symptoms in young adulthood: Is this ADHD?	Riglin L et al.	—	2022	→
Longer screen time utilization is associated with the polygenic risk for Attention-deficit/hyperactivity disorder with mediation by brain white matter microstructure.	Yang A et al.	—	2022	→
Longitudinal Temperament Pathways to ADHD Between Childhood and Adolescence.	Martel MM et al.	—	2022	→
Loss of function of OTUD7A in the schizophrenia- associated 15q13.3 deletion impairs synapse development and function in human neurons.	Kozlova A et al.	—	2022	→
Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobank.	Bracher-Smith M et al.	—	2022	→
Mainstreaming adult ADHD into primary care in the UK: guidance, practice, and best practice recommendations.	Asherson P et al.	—	2022	→
Mapping Complex Brain Torque Components and Their Genetic Architecture and Phenomic Associations in 24,112 Individuals.	Zhao L et al.	—	2022	→
MEF2C gene variations are associated with ADHD in the Chinese Han population: a case-control study.	Fu X et al.	—	2022	→
Mendelian randomisation studies of Attention Deficit Hyperactivity Disorder.	Riglin L et al.	—	2022	→
Mendelian randomization analyses support causal relationships between brain imaging-derived phenotypes and risk of psychiatric disorders.	Guo J et al.	—	2022	→
Meta-analysis of genome-wide association studies of hoarding symptoms in 27,537 individuals.	Strom NI et al.	—	2022	→
MicroRNA binding site variation is enriched in psychiatric disorders.	Geaghan MP et al.	—	2022	→
Molecular genetics of cocaine use disorders in humans.	Fernàndez-Castillo N et al.	—	2022	→
Mother's and children's ADHD genetic risk, household chaos and children's ADHD symptoms: A gene-environment correlation study.	Agnew-Blais JC et al.	—	2022	→
Motivation and Cognitive Abilities as Mediators Between Polygenic Scores and Psychopathology in Children.	Pat N et al.	—	2022	→
Multivariate genome-wide association study on tissue-sensitive diffusion metrics highlights pathways that shape the human brain.	Fan CC et al.	—	2022	→
Neuroimaging Findings in Neurodevelopmental Copy Number Variants: Identifying Molecular Pathways to Convergent Phenotypes.	Silva AI et al.	—	2022	→
Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings.	Biro O et al.	—	2022	→
Neuromorphological and Neurofunctional Correlates of ADHD and ADD in the Auditory Cortex of Adults.	Serrallach BL et al.	—	2022	→
Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan.	Dutta CN et al.	—	2022	→
Non-mental diseases associated with ADHD across the lifespan: Fidgety Philipp and Pippi Longstocking at risk of multimorbidity?	Kittel-Schneider S et al.	—	2022	→
Perinatal depression is associated with a higher polygenic risk for major depressive disorder than non-perinatal depression.	Kiewa J et al.	—	2022	→
Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis.	Misiak B et al.	—	2022	→
Perspectives on heterogeneity-informed cognitive training for attention-deficit/hyperactivity disorder.	Zhang DW	—	2022	→
Phenotypic and genetic analysis of a wellbeing factor score in the UK Biobank and the impact of childhood maltreatment and psychiatric illness.	Jamshidi J et al.	—	2022	→
Polygenic heterogeneity in antidepressant treatment and placebo response.	Nøhr AK et al.	—	2022	→
Polygenic risk for mental disorder reveals distinct association profiles across social behaviour in the general population.	Schlag F et al.	—	2022	→
Polygenic risk scores and early manifestations of attention-deficit/hyperactivity disorder.	Larsson H et al.	—	2022	→
Polygenic scores: prediction versus explanation.	Plomin R et al.	—	2022	→
Population-level variation in enhancer expression identifies disease mechanisms in the human brain.	Dong P et al.	—	2022	→
Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease.	Rodríguez-Urgellés E et al.	—	2022	→
Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder.	Park JH	—	2022	→
Prenatal risk factors and genetic causes of ADHD in children.	Kian N et al.	—	2022	→
Preschool development, temperament and genetic liability as early markers of childhood ADHD: A cohort study.	Tobarra-Sanchez E et al.	—	2022	→
Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD.	Yde Ohki CM et al.	—	2022	→
Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences.	Pereira S et al.	—	2022	→
Psychiatric traits and intracerebral hemorrhage: A Mendelian randomization study.	Wang Q et al.	—	2022	→
Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.	Tourjman V et al.	—	2022	→
Pupil size and pupillary light reflex in early infancy: heritability and link to genetic liability to schizophrenia.	Portugal AM et al.	—	2022	→
Putting Genetics to Work in the Psychiatric Clinic.	McMahon FJ	—	2022	→
Quantitative multidimensional phenotypes improve genetic analysis of laterality traits.	Schmitz J et al.	—	2022	→
Rare copy number variation in posttraumatic stress disorder.	Maihofer AX et al.	—	2022	→
Reconstructing SNP allele and genotype frequencies from GWAS summary statistics.	Yang Z et al.	—	2022	→
Reduced Glx and GABA Inductions in the Anterior Cingulate Cortex and Caudate Nucleus Are Related to Impaired Control of Attention in Attention-Deficit/Hyperactivity Disorder.	Mamiya PC et al.	—	2022	→
Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression.	Li S et al.	—	2022	→
Reliability, Factor Validity, and Neuropsychological Correlates of the Child Concentration Inventory-2 in a Community Sample of Italian Adolescents.	Somma A et al.	—	2022	→
Research Review: How to interpret associations between polygenic scores, environmental risks, and phenotypes.	Pingault JB et al.	—	2022	→
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth.	Birmaher B et al.	—	2022	→
scGWAS: landscape of trait-cell type associations by integrating single-cell transcriptomics-wide and genome-wide association studies.	Jia P et al.	—	2022	→
Sex differences in gene regulatory networks during mid-gestational brain development.	de Toledo VHC et al.	—	2022	→
Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.	Eissman JM et al.	—	2022	→
Sex-different interrelationships of rs945270, cerebral gray matter volumes, and attention deficit hyperactivity disorder: a region-wide study across brain.	Luo X et al.	—	2022	→
Sex-heterogeneous SNPs disproportionately influence gene expression and health.	Traglia M et al.	—	2022	→
Shared Genetic Factors Contributing to the Overlap between Attention-Deficit/Hyperactivity Disorder Symptoms and Overweight/Obesity in Swedish Adolescent Girls and Boys.	Javaras KN et al.	—	2022	→
Shared genetic influences on resting-state functional networks of the brain.	P O F T Guimarães J et al.	—	2022	→
Shared genetic links between frontotemporal dementia and psychiatric disorders.	Li C et al.	—	2022	→
Shared genetics and causality underlying epilepsy and attention-deficit hyperactivity disorder.	Wu Y et al.	—	2022	→
Shared genetics between autism spectrum disorder and attention-deficit/hyperactivity disorder and their association with extraversion.	Baranova A et al.	—	2022	→
Spatiotemporal and genetic regulation of A-to-I editing throughout human brain development.	Dredge WH et al.	—	2022	→
Specific dopaminergic genetic variants influence impulsivity, cognitive deficit, and disease severity of Indian ADHD probands.	Maitra S et al.	—	2022	→
Statistical and functional convergence of common and rare genetic influences on autism at chromosome 16p.	Weiner DJ et al.	—	2022	→
Stratification of individuals with lifetime depression and low wellbeing in the UK Biobank.	Fabbri C et al.	—	2022	→
Stratifying the autistic phenotype using electrophysiological indices of social perception.	Mason L et al.	—	2022	→
Stress-related genetic components in attention-deficit/hyperactivity disorder (ADHD): Effects of the SERPINA6 and SERPINA1 genetic markers in a family-based brazilian sample.	Carpena MX et al.	—	2022	→
Structural network alterations in focal and generalized epilepsy assessed in a worldwide ENIGMA study follow axes of epilepsy risk gene expression.	Larivière S et al.	—	2022	→
Systemic inflammatory regulators and 7 major psychiatric disorders: A two-sample Mendelian randomization study.	Chen X et al.	—	2022	→
Targeting PI3K by Natural Products: A Potential Therapeutic Strategy for Attention-deficit Hyperactivity Disorder.	Noori T et al.	—	2022	→
The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia.	Nehme R et al.	—	2022	→
The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates.	Hatoum AS et al.	—	2022	→
The Australian Genetics of Depression Study: New Risk Loci and Dissecting Heterogeneity Between Subtypes.	Mitchell BL et al.	—	2022	→
The consequences of a year of the COVID-19 pandemic for the mental health of young adult twins in England and Wales.	Rimfeld K et al.	—	2022	→
The dopamine transporter gene SLC6A3: multidisease risks.	Reith MEA et al.	—	2022	→
The epidemiological evidence linking exposure to ambient particulate matter with neurodevelopmental disorders: A systematic review and meta-analysis.	Lin LZ et al.	—	2022	→
The Genetic and Neural Substrates of Externalizing Behavior.	Baselmans B et al.	—	2022	→
The genetic architecture of pneumonia susceptibility implicates mucin biology and a relationship with psychiatric illness.	Reay WR et al.	—	2022	→
The impact and causal directions for the associations between diagnosis of ADHD, socioeconomic status, and intelligence by use of a bi-directional two-sample Mendelian randomization design.	Michaëlsson M et al.	—	2022	→
The next 10 years of behavioural genomic research.	Plomin R	—	2022	→
The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder.	Ben Hamida S et al.	—	2022	→
The relationship between executive function, processing speed, and attention-deficit hyperactivity disorder in middle childhood.	Sabhlok A et al.	—	2022	→
The relationship between persistent organic pollutants and Attention Deficit Hyperactivity Disorder phenotypes: Evidence from task-based neural activity in an observational study of a community sample of Canadian mother-child dyads.	Sussman TJ et al.	—	2022	→
The role of ADHD genetic risk in mid-to-late life somatic health conditions.	Garcia-Argibay M et al.	—	2022	→
The shared genetic basis of mood instability and psychiatric disorders: A cross-trait genome-wide association analysis.	Hindley G et al.	—	2022	→
The Use of <i>Drosophila</i> to Understand Psychostimulant Responses.	Philyaw TJ et al.	—	2022	→
Thirty novel sequence variants impacting human intracranial volume.	Nawaz MS et al.	—	2022	→
Transcriptional programs regulating neuronal differentiation are disrupted in DLG2 knockout human embryonic stem cells and enriched for schizophrenia and related disorders risk variants.	Sanders B et al.	—	2022	→
Uncovering the genetic architecture of broad antisocial behavior through a genome-wide association study meta-analysis.	Tielbeek JJ et al.	—	2022	→
Unique prediction of developmental psychopathology from genetic and familial risk.	Loughnan RJ et al.	—	2022	→
Using DNA to predict behaviour problems from preschool to adulthood.	Gidziela A et al.	—	2022	→
Using the alluvial plot to visualize the network characteristics of 100 top-cited articles on attention-deficit/hyperactivity disorder (ADHD) since 2011: Bibliometric analysis.	Tsai YC et al.	—	2022	→
What Do We Know About the Genetic Architecture of Psychopathology?	Giangrande EJ et al.	—	2022	→
What value do norepinephrine/dopamine dual reuptake inhibitors have to the current treatment of adult attention deficit hyperactivity disorder (ADHD) treatment armamentarium?	Perugi G et al.	—	2022	→
Zebrafish, Medaka and Turquoise Killifish for Understanding Human Neurodegenerative/Neurodevelopmental Disorders.	Kodera K et al.	—	2022	→
Zika virus-induced TNF-α signaling dysregulates expression of neurologic genes associated with psychiatric disorders.	Kung PL et al.	—	2022	→
A Biased Perspective on Brain Imaging of ADHD.	Castellanos FX	—	2021	→
A Comprehensive Evaluation of Cross-Omics Blood-Based Biomarkers for Neuropsychiatric Disorders.	Song W et al.	—	2021	→
A comprehensive gene-centric pleiotropic association analysis for 14 psychiatric disorders with GWAS summary statistics.	Lu H et al.	—	2021	→
Alcohol use disorders and ADHD.	Luderer M et al.	—	2021	→
Alternative models for transgenerational epigenetic inheritance: Molecular psychiatry beyond mice and man.	Hime GR et al.	—	2021	→
Analysis of genetic differences between psychiatric disorders: exploring pathways and cell types/tissues involved and ability to differentiate the disorders by polygenic scores.	Rao S et al.	—	2021	→
An atlas of gene regulatory elements in adult mouse cerebrum.	Li YE et al.	—	2021	→
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings.	Maxwell JM et al.	—	2021	→
Association between polygenic propensity for psychiatric disorders and nutrient intake.	Hunjan AK et al.	—	2021	→
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study.	Coombes BJ et al.	—	2021	→
Association of Maternal Depressive Symptoms During the Perinatal Period With Oppositional Defiant Disorder in Children and Adolescents.	Dachew BA et al.	—	2021	→
Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia.	Legge SE et al.	—	2021	→
Autophagy, apoptosis, and neurodevelopmental genes might underlie selective brain region vulnerability in attention-deficit/hyperactivity disorder.	Hess JL et al.	—	2021	→
Brain-trait-associated variants impact cell-type-specific gene regulation during neurogenesis.	Aygün N et al.	—	2021	→
Combining multivariate genomic approaches to elucidate the comorbidity between autism spectrum disorder and attention deficit hyperactivity disorder.	Peyre H et al.	—	2021	→
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.	van Rheenen W et al.	—	2021	→
Comparison of methods for estimating genetic correlation between complex traits using GWAS summary statistics.	Zhang Y et al.	—	2021	→
Comprehensive multi-omics integration identifies differentially active enhancers during human brain development with clinical relevance.	Yousefi S et al.	—	2021	→
Contribution of birth weight to mental health, cognitive and socioeconomic outcomes: two-sample Mendelian randomisation.	Orri M et al.	—	2021	→
Cross-Disorder Genomics Data Analysis Elucidates a Shared Genetic Basis Between Major Depression and Osteoarthritis Pain.	Barowsky S et al.	—	2021	→
Deep learning model reveals potential risk genes for ADHD, especially Ephrin receptor gene EPHA5.	Liu L et al.	—	2021	→
Discordant associations of educational attainment with ASD and ADHD implicate a polygenic form of pleiotropy.	Verhoef E et al.	—	2021	→
Dissect Relationships Between Gene Co-expression and Functional Connectivity in Human Brain.	Zhang X et al.	—	2021	→
Distinct effect of prenatal and postnatal brain expression across 20 brain disorders and anthropometric social traits: a systematic study of spatiotemporal modularity.	Jia P et al.	—	2021	→
Early environmental risk factors for neurodevelopmental disorders - a systematic review of twin and sibling studies.	Carlsson T et al.	—	2021	→
Elevated common variant genetic risk for tourette syndrome in a densely-affected pedigree.	Halvorsen M et al.	—	2021	→
Elevated risk of attention deficit hyperactivity disorder (ADHD) in Japanese children with higher genetic susceptibility to ADHD with a birth weight under 2000 g.	Rahman MS et al.	—	2021	→
E-MAGMA: an eQTL-informed method to identify risk genes using genome-wide association study summary statistics.	Gerring ZF et al.	—	2021	→
Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression.	Martin J et al.	—	2021	→
Exploring the Contribution to ADHD of Genes Involved in Mendelian Disorders Presenting with Hyperactivity and/or Inattention.	Fernàndez-Castillo N et al.	—	2021	→
Familial liability to asthma and ADHD: A Swedish national register-based study.	Sun S et al.	—	2021	→
Fertility Outcomes, Heritability and Genomic Associations of In-Group Preference and In-Group Marriage.	Fieder M et al.	—	2021	→
Gene-Environment Interactions in Attention-Deficit/Hyperactivity Disorder Symptom Dimensions: The Role of Unhealthy Food Habits.	Li L et al.	—	2021	→
Genetic risks, adolescent health, and schooling attainment.	Amin V et al.	—	2021	→
Genetics on the neurodiversity spectrum: Genetic, phenotypic and endophenotypic continua in autism and ADHD.	Koi P	—	2021	→
Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study.	Ni JJ et al.	—	2021	→
Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder.	Richarte V et al.	—	2021	→
Haploinsufficiency of the Attention-Deficit/Hyperactivity Disorder Risk Gene <i>St3gal3</i> in Mice Causes Alterations in Cognition and Expression of Genes Involved in Myelination and Sialylation.	Rivero O et al.	—	2021	→
Identification of pleiotropy at the gene level between psychiatric disorders and related traits.	Polushina T et al.	—	2021	→
<i>DRD1</i> and <i>DRD2</i> Receptor Polymorphisms: Genetic Neuromodulation of the Dopaminergic System as a Risk Factor for ASD, ADHD and ASD/ADHD Overlap.	Mariggiò MA et al.	—	2021	→
Increased locomotor activity via regulation of GABAergic signalling in foxp2 mutant zebrafish-implications for neurodevelopmental disorders.	Lüffe TM et al.	—	2021	→
Increased pupil dilation to happy faces in children with hyperactive/impulsive symptoms of ADHD.	Kleberg JL et al.	—	2021	→
Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis.	He Q et al.	—	2021	→
Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD.	García-Marín LM et al.	—	2021	→
Magnetic Resonance Fingerprinting of the Pediatric Brain.	Hung SC et al.	—	2021	→
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review.	Jaeschke RR et al.	—	2021	→
Molecular networks of the FOXP2 transcription factor in the brain.	den Hoed J et al.	—	2021	→
Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction.	Karlsson Linnér R et al.	—	2021	→
Polygenic Heterogeneity Across Obsessive-Compulsive Disorder Subgroups Defined by a Comorbid Diagnosis.	Strom NI et al.	—	2021	→
Polygenic risk score for bipolar disorder associates with divergent thinking and brain structures in the prefrontal cortex.	Takeuchi H et al.	—	2021	→
Powerful gene-based testing by integrating long-range chromatin interactions and knockoff genotypes.	Ma S et al.	—	2021	→
Prognostic value of polygenic risk scores for adults with psychosis.	Landi I et al.	—	2021	→
Sex differences in the genetic regulation of the blood transcriptome response to glucocorticoid receptor activation.	Moore SR et al.	—	2021	→
Shared sets of correlated polygenic risk scores and voxel-wise grey matter across multiple traits identified via bi-clustering.	Rahaman MA et al.	—	2021	→
Single-cell alternative polyadenylation analysis delineates GABAergic neuron types.	Yang Y et al.	—	2021	→
Single-nucleus transcriptome analysis reveals cell-type-specific molecular signatures across reward circuitry in the human brain.	Tran MN et al.	—	2021	→
Sites of active gene regulation in the prenatal frontal cortex and their role in neuropsychiatric disorders.	Kouakou MR et al.	—	2021	→
SnapHiC: a computational pipeline to identify chromatin loops from single-cell Hi-C data.	Yu M et al.	—	2021	→
SUPERGNOVA: local genetic correlation analysis reveals heterogeneous etiologic sharing of complex traits.	Zhang Y et al.	—	2021	→
The association between polygenic scores for attention-deficit/hyperactivity disorder and school performance: The role of attention-deficit/hyperactivity disorder symptoms, polygenic scores for educational attainment, and shared familial factors.	Jangmo A et al.	—	2021	→
The Babytwins Study Sweden (BATSS): A Multi-Method Infant Twin Study of Genetic and Environmental Factors Influencing Infant Brain and Behavioral Development.	Falck-Ytter T et al.	—	2021	→
The link between attention deficit hyperactivity disorder (ADHD) symptoms and obesity-related traits: genetic and prenatal explanations.	Karhunen V et al.	—	2021	→
The Monash Autism-ADHD genetics and neurodevelopment (MAGNET) project design and methodologies: a dimensional approach to understanding neurobiological and genetic aetiology.	Knott R et al.	—	2021	→
The role of glucocorticoid receptor gene in the association between attention deficit-hyperactivity disorder and smaller brain structures.	Bandeira CE et al.	—	2021	→